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ABSTRACT 
Pregnancy is often portrayed as a happy time for the woman and her family. In 
reality, many women struggle with negative emotions and moods that can have 
deleterious effects on the mother, the fetus, and the growing family. Depression is an 
increasing, worldwide problem, with women in their childbearing years and those of low 
socioeconomic status the most vulnerable.  
This study explores depression, as determined by the Edinburgh Postnatal 
Depression Scale (EPDS), in a high-risk sample of pregnant women enrolled in two 
prenatal programs in Saskatoon, Saskatchewan, Canada. A prevention and population 
health approach has been used to identify potential determinants and implications of 
antenatal depression. The data analyzed in this study were from the first cross-sectional 
portion of a longitudinal, epidemiological study of depression in pregnancy into the 
postpartum. Women were invited to participate in the study at their first prenatal visit. 
Data were collected by program staff.  
The prevalence of depression in this sample of 402 high-risk women was 29.5%, 
which is similar to other studies of inner-city, low income, and minority women 
elsewhere in the world. In the final model, antenatal depression was associated with a 
history of depression, moods going up and down, current smoking status, high levels of 
stressors, and social support. 
Factor analysis of the EPDS revealed three underlying factors: Anxiety, 
Depression, and Self-harm thoughts. The anxiety factor explained most of the variance in 
the overall EPDS scores in this sample of women. A history of problems with mood 
fluctuations was significantly associated with anxiety and depression subscales and self-
harm. Significantly more women aged 21 and under experienced anxiety, and more 
Aboriginal women experienced depressive symptoms and self-harm thoughts. Twenty 
percent of women reported self-harm thoughts in the preceding seven days. Depressed, 
Aboriginal, and single women, and women who use alcohol were most at risk for self-
harm thoughts.  
The level of depressive symptoms in this sample of women represents a 
significant public and mental health problem in women already challenged by inequities 
in their life circumstances. We need to develop public health policy that will support 
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screening and identification of women with depression. Interventions at the primary, 
secondary, and tertiary levels of prevention can help to improve the health of women 
struggling with antenatal depression, promote the optimal intrauterine environment for 
their unborn children, and reduce the intergenerational transmission of depression.  
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CHAPTER 1 
INTRODUCTION 
Pregnancy is portrayed as a joyous time. Contrary to this perception, women are at 
the highest risk for depression during their childbearing years than at any other time in 
their lives.(1, 2) Mental health issues are more common than other medical and obstetrical 
problems that women are routinely screened and treated for in pregnancy.(3, 4) The 
prevalence of depression in pregnancy and after birth varies from 10-39%, with inner-city 
women at the highest risk.(5, 6) According to the literature, single women who live in 
poverty, and experience family discord or violence, increased life stress, and have little 
social support are more likely to be depressed.(6-11) However, there continue to be 
contradictory reports regarding the correlates and determinants of antenatal depression.(12-
14) 
Pregnant women who are depressed are more likely to use alcohol, drugs, and 
tobacco and are less likely to have adequate prenatal care, all of which contribute to poor 
outcomes for the fetus, the baby, and the mother herself.(10, 15, 16) They are at risk for more 
severe depressions, psychosis, and suicide.(17-20) Their pregnancies end prematurely and 
have more obstetrical complications.(4)  
Depression during pregnancy is particularly significant not just because of the 
consequences to the health of the mother, but also the potential deleterious effects on the 
developing fetus.(2) Barker, in his theory of the “fetal origins of adult disease”, 
hypothesized that the prenatal environment exerts influences on fetal health that, in turn, 
follow into adulthood.(21) Therefore, furthering our understanding of the prevalence and 
determinants of depression in pregnancy may be essential to reducing the 
intergenerational spread of the sequelae caused by depression.  
Infants of depressed women are at greater risk for pre-term delivery, low birth 
weight, failure to thrive, and are breastfed less.(22-25) As children, they experience more 
growth, psychological, behavioural, and developmental problems.(24-28) Routine prenatal 
visits offer an ideal opportunity for early detection and intervention of depression;(18, 29-31) 
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however, neither the full extent nor implications of antenatal depression are usually 
recognized by the obstetric, mental health, or family practice health services. 
Consequently, there is no routine screening for depression in pregnancy within the 
Saskatoon Health Region.  
The data analyzed in this thesis were collected as part of a larger, longitudinal 
epidemiological study of depressive symptoms and associated sociodemographic, 
obstetrical/biological, psychosocial, and behavioural determinants over the course of 
pregnancy and into the early postpartum. Staff, clients, and management of two local 
agencies that provide antenatal and postpartum services to high-risk women in Saskatoon 
have been involved in the study design, questionnaire development, and data collection 
for this research project.  
It is anticipated that this research will add to the growing body of knowledge 
about antenatal depression, particularly in high-risk women. Increased understanding 
about the prevalence and determinants associated with antenatal depression will inform 
researchers and caregivers about the factors affecting fetal and child development and 
family well-being. Screening and early intervention of antenatal depression may help to 
prevent complications for the mother and her baby. It is hoped that the findings will 
increase awareness of vulnerable pregnant women who are struggling with depression 
and their life circumstances in our community. Finally, this research will assist 
administrators in the development of health policy and mental health services for 
pregnant women in the health region. 
1.1 Purpose 
The purpose of this project is to increase our understanding of depression in a 
selected group of low socioeconomic, low education, mostly Aboriginal pregnant women 
in Saskatoon. It will determine the prevalence, as well as the sociodemographic, 
obstetrical/biological, psychosocial, and behavioural determinants of depressive 
symptoms. Determining the prevalence and determinants of depression in pregnancy can 
help us to target women at increased risk for screening and prevention. There is increased 
opportunity to anticipate those women at risk for depression and consequently to reduce 
the impact of antenatal depression on the mother, her baby, and her family. 
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1.2 Research Questions and Hypotheses  
The study will investigate the following five research questions and respective 
hypotheses. These questions begin with an estimation of simple prevalence rates and then 
progress to more specific questions to identify the determinants of depression in the 
sample and in different subgroups of women, and end with an in-depth analysis of the 
depression scale. The symptom profile of depression in the total sample of women and 
the different subgroups of women will be explored and compared.  
1.2.1 Question 1 What is the prevalence of antenatal depression in this 
sample of high-risk women and is this prevalence different from rates reported in the 
literature for comparable groups? 
Hypothesis: The prevalence of depressive symptoms in this selected sample of 
pregnant women will be comparable to prevalence reported in the literature for high-risk 
women and fall within the range of 25% to 47%. 
1.2.2 Question 2 What are the sociodemographic, obstetrical/biological, 
psychological, and behavioural determinants of antenatal depression in this group of 
high-risk women? 
Hypothesis: Antenatal women with major depressive symptoms will be of lower 
income, lower levels of education, more single status, and younger, they will have more 
pregnancies, more abortions, and more somatic complaints, more psychological 
problems, and engage in more risk behaviours compared to women with no or low 
depressive symptoms.  
1.2.3 Question 3 What are the prevalence and determinants of antenatal 
depression in Aboriginal women compared to non-Aboriginal women, women 21 and 
under compared to women 21 and over, and non-partnered women compared to partnered 
women?  
Hypothesis: Aboriginal women will experience higher levels of depression than 
non-Aboriginal women will. Women 21 and under will experience more depression 
compared to women over 21. Non-partnered women will experience more depression 
than women with partners will. 
1.2.4 Question 4 Does the Edinburgh Postnatal Depression Scale develop 
into constituent measures of depression, how do they contribute to the overall score, and 
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what are the determinants associated with these constituent measures in this sample of 
high-risk women? 
 Hypothesis: The Edinburgh Postnatal Depression Scale will have more than one 
underlying factor. These factors will have unique contributions to the depression score 
and will have different associations with the determinants.  
1.2.5 Question 5 Are the constituent measures on the Edinburgh Postnatal 
Scale different for the subgroups of women (e.g., younger, Aboriginal, non-partnered)? 
Hypothesis: It is hypothesized that there will be differences in the factors of 
depression in Aboriginal women compared to non-Aboriginal women, women 21 and 
under compared to women over 21, and non-partnered women compared to partnered 
women.  
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CHAPTER 2 
LITERATURE REVIEW 
A review of antenatal depression was written for the Canadian Nurse.(32) Chapter 
2 describes the epidemiology and signs and symptoms of depression. The prevalence and 
determinants of depression and anxiety in pregnancy, particularly in high-risk women are 
discussed. The chapter ends with the effects of depression on the woman, the pregnancy, 
the fetus, the child, and the family.  
2.1 Epidemiology of Depression 
The World Health Organization (WHO) estimates that by the year 2020, 
depression will be the second greatest cause of disease burden in both sexes. (33) Sadly, it 
is already the leading cause of disease burden in women aged 15-44 worldwide.(33) In 
Canada, depression is a major public health problem that affects up to 7% of all women, 
with a lifetime prevalence in women of 12.3%.(1)  Women have twice the risk of 
experiencing depression in their lifetime than men.(1, 2) This difference begins early in 
puberty, around the start of the menarche, and it remains highly elevated until after the 
menopause, but still does not return to the level of men.(1) Women are more likely to be 
depressed during pregnancy, or in the postpartum period, or throughout pre and 
postpartum than at any other time in their lives.(1, 2) 
2.2 Depression 
Depression is an emotional or affective state where a person may feel sad, lonely, 
or miserable with a “lack of interest” in their usual pleasurable activities.(34) The stimulus 
for depression can range from an appropriate response to loss or trauma, life situation, a 
vulnerability rooted in underlying genetic make-up, or complex biological causes.(17), (35, 
36)   
It has been posited that genetics play an important role in the development of 
depression.(35) There is a 25% to 33% increased rate of depression in first-degree relatives 
of people with depression, with the lifetime risk of depression in children of depressed
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parents ranging from 15-45%; but depression also occurs in people with no family 
history.(35, 36) The XX female genetic composition (compared to the male XY) may also 
increase a woman’s susceptibility for depression.(35, 36)  
Changes in the levels of female sex-related hormones (i.e., estrogen, 
progesterone) at adolescence, during menstrual cycles, throughout pregnancy, at 
postpartum, and into menopause are often blamed for the discrepancy between the rates 
of depression in men and women, particularly throughout the childbearing years.(37) 
Estrogen is believed to have effects on neurotransmitters, including serotonin, which are 
directly associated with depression and are also linked to anxiety.(37, 38) Women also have 
differences in thyroid function, cortisol, monamine oxidase transmitters (MAO), and 
adrenocortiocotropic hormone (ACTH), which may increase susceptibility for depression. 
The different hormones and neurotransmitters are also shown to have a sex-differentiated 
effect on the hypothalamic-pituitary-adrenal axis (HPA), which modulates mood in 
response to stress.(37-39) 
Along with genetic and biological vulnerability, early stress such as life traumas 
(e.g., loss of parent or abuse) are linked to changes in the central nervous and endocrine 
systems, which are detrimental to the hippocampus and also further increase the risk for 
depression.(40)  
2.3 Signs and Symptoms of Depression 
According to the American Psychiatric Association (APA), a diagnosis of major 
depressive disorder exists if a person experiences five or more of the following signs or 
symptoms in a two-week period. At least one of the symptoms must be either depressed 
mood or anhedonia (severely diminished interest or pleasure in activities that were 
previously enjoyable) and the person must have some impairment to their life:(17, 41) 
• Depressed mood most of the day 
• Anhedonia 
• Significant weight loss or gain of more than 5% of body weight in 1 month 
• Insomnia or hypersomnia almost every day 
• Psychomotor changes as observed by others (restless, agitated, or slowed) 
• Fatigue or diminished energy level 
• Feelings of worthlessness or excessive or inappropriate guilt 
• Decreased concentration or indecisiveness 
• Recurrent thoughts of death, a suicide plan, or attempt  
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A person who has at least two, but no more than five, of the above symptoms for two 
weeks, with one of the symptoms being depressed mood or anhedonia, may have minor 
depression.(34) The signs and symptoms of depression in pregnancy do not differ from the 
signs and symptoms of depression at any other time.(42, 43) 
2.4 Antenatal Depression 
Traditionally, pregnancy was viewed as a time protective against developing 
depression; consequently, the existence and consequences of antenatal depression (AD) 
have received little attention in either obstetrical, psychiatric, family medical practice, or 
mental health services.(19, 44, 45) However, melancholia in pregnancy was noted as early as 
1840.(19, 46) As recently as the 1970 s, the elevated progesterone and estrogen levels 
associated with pregnancy were viewed as protective for depression.(19, 47) Kendell further 
contributed to the impression that pregnancy is a time of low psychiatric problems.(46) He 
studied admissions to psychiatric units in 2,000 women throughout the antenatal and 
postnatal period and found the rates lowest in the second trimester of pregnancy of all the 
perinatal period. Kendell credited the low rate of hospitalizations, particularly for 
psychosis, to a lack of psychiatric problems during pregnancy; however, he did not 
include admissions to obstetrical wards or other units, which may have biased the 
findings.(19, 48)  
Focus on the physical well-being of the mother and fetus, and attributing a 
woman’s complaints (such as fatigue, appetite, and weight changes) to the physical or 
hormonal changes of pregnancy can mask the symptoms of depression and has probably 
contributed to an under-diagnosis of antenatal depression.(47, 49, 50) Kelly et al. confirmed 
that somatic complaints may not all be normal manifestations associated with the 
pregnancy, with the number and intensity of somatic symptoms significantly increased in 
depressed compared to non-depressed pregnant women.(49) Therefore, increased amount 
or excessive severity of physical complaints during pregnancy should alert care providers 
to assess women for depression rather than dismissing them as typical symptoms 
associated with pregnancy.(49, 50) 
Pregnancy is a time associated with unfolding and changing physical and 
psychological challenges, unique in each of the three trimesters. The first trimester begins 
at conception and lasts until 13 weeks gestation. The pregnant woman may experience 
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fatigue, nausea, vomiting, altered appetite, and physical changes. She may be ambivalent 
about the pregnancy. There is emotional lability with increased forgetfulness and 
introspectiveness and the woman may experience depression. In the second trimester 
(weeks 13 to 26), the pregnancy becomes obvious as the uterus rises out of the pelvis. 
There is a decrease in physical complaints. The woman becomes increasingly pensive; 
she fantasizes more about the baby, and her attachment to the fetus increases as she 
experiences the fetus move inside her. A woman is likely to be psychologically and 
physically robust; it is purported by some to be the least probable time for depressive 
symptoms in either pregnancy or in the postpartum period.(48) The third trimester (26 
weeks to delivery) usually brings increased complaints of fatigue, low energy, and 
insomnia due to increased fetal activity and physical discomforts. The woman may be 
very self-absorbed and may experience increasing anxiety about the birth and impending 
motherhood. A woman is assumed to be more susceptible to depression now than at any 
other time in pregnancy.(19, 48, 51, 52)  
There is an assumption that pregnancy is a time of increased emotionality with 
expectations of frequent fluctuations in mood.(53) However, mood swings may not 
necessarily be normal and are often associated with increased emotional distress and 
irritability as well as increased comorbidity of psychiatric problems such as borderline 
personality, anxiety, and depression.(54, 55) 
In a recent systematic review of antenatal depression, Bennett et al. analyzed 21 
studies. Many of these studies did not have antenatal depression as the main outcome 
measure nor did they all include women in early pregnancy.(5) As Table 2.1 shows, the 
prevalence of antenatal depression varied greatly from 7.4% to 51.4% in general 
populations of pregnant women. The studies used a variety of depression screening tools 
and it is not clear whether all of these tools were adjusted for the somatic complaints that 
may confound the symptoms of depression in pregnant women. The prevalence of 
antenatal depression was less variable, although consistently high, among the low-
socioeconomic status women.  
 
Table 2.1 Prevalence of antenatal depression(5) 
Prevalence 1st 
Trimester 
2nd 
Trimester 
3rd 
Trimester 
General population 7.4 - 24.6% 9.1 - 48.9% 8.8 - 51.4% 
Low-socioeconomic Not available 28 - 47% 25 – 39% 
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In one of the larger studies of antenatal depression in primary care, Marcus et al. 
reported a prevalence of 20% in 3,472 pregnant women (mean gestation 25 weeks). This 
estimate falls within the range as reported in the systematic review for the second 
trimester. Further, the researchers found that only 13% of those women identified as 
depressed were receiving care for the depression.(56)  The Confidential Enquiries into 
Maternal Deaths (CEMD) in the United Kingdom determined that 12% of all maternal 
deaths (death during pregnancy and in the first year post delivery) could be ascribed to 
psychiatric illness, with suicide the leading cause of death, surpassing all medical or 
obstetrical problems.(57)  
In addition to the usual predictors of depression, antenatal depression has been 
uniquely associated with a history of previous abortions, ambivalence towards the 
pregnancy, including thoughts of abortion, and anxiety about the fetus.(19, 58)  
2.5 Anxiety in Pregnancy 
Anxiety disorders are amongst the most prevalent of the psychiatric disorders, 
affecting approximately 16% of women in Canada, with some epidemiologic studies 
estimating a 30% lifetime prevalence.(59-61) There is limited study or awareness about the 
prevalence of anxiety during pregnancy. Women’s reporting of excessive worry or 
anxious feelings may be treated by caregivers as the normal concern of expectant mothers 
rather giving them a proper examination of their symptoms for anxiety. In a study of 
8,000 pregnant women in Great Britain, 21.9% had anxiety symptoms (62) and 24.1% of 
497 women in France were reported to suffer with anxiety during pregnancy.(63)  
Anxiety is an important feature in the research and understanding of depression. A 
temporal relationship has been identified between anxiety and the subsequent 
development of depression in some people.(64) Consequently, identifying and treating 
anxiety may help to prevent depression.(64, 65) This is particularly relevant in childbearing 
women as anxiety during pregnancy has been identified as an important precursor to 
postpartum depression.(63) Women who experience anxiety are up to three times as likely 
to report severe postpartum depression symptoms compared to women without anxiety.(62, 
63, 66) 
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2.6 Depression in High-Risk Pregnant Women 
Women who are non-partnered, with low socioeconomic status, low education, or 
ethnic minorities may face many challenges that compromise their ability to have healthy 
pregnancies and may possibly put them at increased risk for developing depression.(7, 12, 
67) Several studies of pregnant women in predominantly inner-city, low income 
neighbourhoods have reported on the prevalence and correlates of depression in high-risk 
pregnant women.(6, 12, 67-69) 
Bolton and associates screened and examined 407 inner-city pregnant women in 
London, UK; 29% screened positive for a clinically significant depression.(67)  The single 
women were 2.43 times more likely to be depressed than those with live-in partners were; 
women with low support from their partners were more than twice as likely to be 
depressed as those with more supportive partners. Unemployed women had a 2.35 times 
greater risk for depression than those who were employed. Multiparous women were 2.62 
more likely than first time mothers to be depressed, and those who did not complete high-
school had 3.40 times the risk of depression than those who had completed school. The 
authors concluded that there should be increased emphasis on education to increase a 
woman’s chances of employment, which might in turn improve their outlook and counter 
depression. Some women in the sample were from more affluent neighbourhoods, which 
may have affected the associations.(67)  
A study of 192 high-risk pregnant women in Ohio focused on the association 
between socioeconomic status, marital status, and ethnicity and depression.(12) Women 
were paid for their participation in the study, which included three interviews, two in 
pregnancy and one in postpartum. Depression was assessed using the Schedule for 
Affective Disorders and Schizophrenia (SADS), adapted for use in pregnancy. They also 
confirmed the diagnosis using the Research Diagnostic Criteria (RDC) with a shortened 
version of the Beck Depression Inventory (BDI). Over 40% of the women met their 
criteria for depression on either of the two antepartum assessments, with point 
prevalences of 27.6% and 24.5%, dropping to 23.4% in the postpartum. Thirty percent of 
women depressed antenatally remained depressed into the postpartum. Only single, non-
cohabiting status was associated with depression in the women. The study had a large loss 
to follow-up, especially among Black women, which may be the reason that the study did 
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not find an association between depression and ethnicity, single status, or low 
socioeconomic status in this group.(12)   
In a Brazilian study, over 37% of 29 inner-city women screened positive for 
depressive symptoms during pregnancy.(6) Researchers only found a significant 
association between Black ethnicity and depression in this high-risk group. The 
prevalence of depression was 13% at three months postpartum, which is consistent with 
rates in the general pregnant population; however, 43% of the women experienced at least 
one episode of depression in the first six months post delivery.(6) The small sample size 
limits generalizability of the findings but does point to a high point prevalence of 
depressive symptoms in this population of women.  
Also in Brazil, Lovisi et al. looked at depression, poverty, and violence in 230 
pregnant women in a public hospital maternity clinic.(69) They determined the prevalence 
of depression at 19.1% using the Composite International Diagnostic Interview (CIDI), a 
tool not specific to screening pregnant women. Almost 60% of the pregnancies were 
unplanned, and 29.9% were primiparous. These factors were positively associated with 
depression in the bivariate analysis. Divorced or widowed women were almost five times 
more likely to be depressed, and the women with a history of depression had 7.9 times the 
likelihood of antenatal depression. The loss of intimate relationship, financial difficulties, 
and family violence in the previous year were all significantly associated with depression. 
Education beyond primary school was protective for depression. The women reported a 
lack of emotional and social support, but there was no association between support and 
depression. The authors reported that this population of women is representative of other 
similar-sized maternity hospitals in Brazil.  
Kim et al. studied the association between prenatal care, psychiatric illness, and 
the sociodemographic characteristics of 154 inner-city women in a mid-western city in 
the United States.(70) Eighty percent of the women were of ethnically diverse backgrounds 
(e.g., 32% African American, 31% Hispanic, and 7% Native). Study tools were available 
in English and Spanish. Almost two-thirds of the women were single and 65% had 
completed high-school. Thirty-one percent of the women screened positively for 
psychiatric illness and/or substance abuse problems, 26% were diagnosed with depression 
and 10% met the criteria for anxiety using the Primary Care Evaluation of Mental 
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Disorders (PRIME-MD). The PRIME-MD is validated for detecting psychiatric 
problems; however it is not confirmed for use in pregnant populations.  
The researchers found that a history of psychiatric problems, but not current 
psychiatric illness, was associated with delayed and inadequate prenatal care, with 44% 
of women initiating prenatal care as late as 16 weeks gestation with ongoing inadequate 
prenatal care. This compares negatively to the American national goal for 90% of women 
to initiate prenatal care in the first trimester (<13 weeks gestation).(71) Women in this 
study with positive psychiatric screens were more likely to report stressors involving the 
partner, finances, and social isolation as well as health and weight concerns.(70)  
In a study of 130 low-income women (16-28 weeks gestation) in an urban prenatal 
clinic in the Midwestern U.S., 27% of the women met the criteria for depression using the 
Beck Depression Inventory-II (BDI-II).(68)  The Beck Depression Inventory is a well-used 
scale for depression screening,(72) but the authors do not state if they have adjusted it for 
use in perinatal women in this study. Sixty percent of the participants were African 
American, 58% were partnered, 33% had not completed high-school, and 78% were 
receiving Medicare (public health insurance). Depression was significantly associated 
with high levels of stress and high religiosity and with low levels of self-esteem and 
social support. While 25% of the African American women screened positive for 
depression compared to 33% of the Caucasian women in the study, this was not a 
statistically significant difference. There were significantly higher levels of depression, 
lower self-esteem, less resources, and lower religiosity but no other differences in the 
younger group of women.(68) 
The make-up of these high-risk populations is specific to their locale and many 
have small sample sizes (see Appendix A). There is limited research in high-risk 
populations of pregnant women in Canadian studies that include Aboriginal women. 
In the Saskatoon Pregnancy and Health Study (SPHS), Muhajarine studied the 
determinants and consequences of risk behaviours in 452 women in Saskatoon in 1993-
1999, 40% of whom were identified as high-risk. He used the Brief Symptom Inventory 
(BSI), a general psychiatric symptom questionnaire, and reported that 33% of the women 
felt moderately lonely or blue in preceding month.(73) Roots and Wings was a study of 
aggression and abuse in a subgroup of 500 primiparous (first time pregnant) women and 
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those with later born children (born to women who had not borne a child 10 years since 
the last one), in a high-risk population in Saskatoon in 2001. They also used the BSI and 
reported a depression rate of 48.6% and 40% anxiety.(74) The BSI was not adjusted for use 
in pregnancy in either of these studies. 
The high prevalence rates of anxiety and depression in pregnancy are a great 
concern for the health of women; however, there is also the potential for widespread 
negative impact on the developing fetus and the growing family. 
2.7 Effects of Depression  
 2.7.1 Effects on the woman and the pregnancy 
Pregnant women who are depressed experience deteriorating social function, and 
they are more emotionally withdrawn, express excessive concern about the pregnancy, 
and their ability to parent.(11, 75) They use tobacco, alcohol, and drugs more often, all of 
which are known to affect placental function and fetal growth.(15, 76, 77) Women with 
depression are less likely to attend regular obstetric visits, comply with prenatal advice, or 
take prenatal vitamins, and they are less informed about the benefits of folic acid than 
non-depressed women are.(10, 16, 70) Pregnant women who are depressed are more likely 
than non-depressed women to abuse their fetus through physical assault such as punching 
the pregnant abdomen, by engaging in risk behaviour such as substance abuse, or by not 
attending to their physical health.(78) 
Untreated depression can lead to psychosis.(37) The prevalence of antenatal 
psychosis is unreported and it is believed to be rare;(79) however, postpartum psychosis 
affects between 0.1- 0.2% of women.(37) Psychosis is a serious illness: psychotic women 
experience hallucinations and delusions,(19) are out of touch with reality, and are at 
increased risk for suicide and homicide.(46, 57)  
The rate of suicide in pregnancy is low, with highest rates sometimes reported in 
younger women(57, 80, 81) but this does not mean that pregnant women do not have suicidal 
or self-harm thoughts. In a review of suicidality in perinatal women, Lindahl et al. 
reported approximately 14% of pregnant women have suicidal ideation.(80) They 
concluded that social support, contact with health care providers, and concern for the 
unborn child work together to reduce the chance of suicide.(80) In two separate studies, 
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when women who were depressed were asked about self-harm thoughts, 40% report self-
harm ideation in the past week at their first prenatal visit.(81, 82)  
Depression is associated with increased medical problems, such as an increased 
risk of gastrointestinal problems including Irritable Bowel Syndrome,(83) cardiac, and 
other medical problems.(84)  Chronic depression is associated with dilated ventricles and 
smaller hippocampal volumes in the adult brain.(85) There are disturbances in serotonin 
and norepinephrine levels, which, along with the increased cortisol levels, furthers the 
risk for depression and the cycle of depression continues and worsens.(40) 
Lack of sleep is linked to an overall lack of well-being, poor decision-making, 
irritability, distorted perception of events, loneliness, anxiety, substance use, and 
increased postpartum psychosis.(86) Sleep in pregnant women may be interrupted by fetal 
movements or physical discomfort and would be increasingly disrupted if a woman was 
also anxious or depressed.(86-88) In addition to the physical effects of depression, the 
expectation to feel happy during pregnancy and after birth of a baby may create confusion 
and guilt for women who are already feeling vulnerable. 
Stress, anxiety, and depression cause the release of maternal corticosteroids such 
as cortisol(89) as well as catecholamines.(25, 90) These substances are believed to cause 
decreased uterine artery blood flow and uterine irritability, which may contribute to the 
increased rates of pre-term delivery observed in anxious and depressed women.(91-94) 
Maternal mental health problems, such as antenatal depression, can alter uterine 
neuroendocrine and hemodynamics.(4, 95, 96)  These changes can increase the risk of 
complications in the pregnancy such as a triple the rate of pre-eclampsia,(97) diabetes,(3) 
2.5 times the chance of having epidural anesthesia,(4) and more than double the rate of 
operative deliveries such as Caesarean Section or use of forceps.(4) 
2.7.2 Effects on the fetus and the child 
Fetal and maternal endocrine levels are highly correlated: increased levels of 
maternal cortisol influence gluccocorticoid receptors in the fetal brain and cause an 
exaggerated pattern of stress response in the fetus itself.(25, 90, 96, 98) Prenatal exposure to 
increased glucocorticoids has been associated with increased risk of cardiovascular, 
metabolic, and neuroendocrine disorders in later life in animal models.(99) Animal studies 
have also shown stress, anxiety, and depression in the mother can alter development of 
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the fetal Hypothalamic-Pituitary-Adrenal (HPA) axis. This can lead to abnormal 
development of neural structures and neuron death, and sustained dysregulation of the 
HPA, which may affect child development and vulnerability to anxiety into adulthood.(100, 
101) In one study, the fetuses of depressed women had elevated baseline fetal heart rates 
(FHR) with a 3.5-fold delay in return to baseline FHR after stimulation.(95)  
Newborns whose mothers were stressed, anxious, or depressed in pregnancy are at 
increased risk for preterm delivery,(93, 102, 103) lower Apgar scores (health assessment of 
newborns measured at 1, 5, 10 minutes of age) and birth weight,(104) and smaller head 
circumference.(105) They score lower on development scales-specifically motor tone and 
activity levels, increased stress behaviours less imitative behaviour, less mature sleep 
patterns, more irritability, as well as increased norepinephrine levels and decreased vagal 
tone.(102, 106) 
Babies of mothers who were depressed in pregnancy experience increased levels 
of cortisol and abnormal brain wave activity,(93) and 2.2 times increased rates of 
admission to the neonatal intensive care.(4) Infants experience less and shorter durations 
of breastfeeding,(107) a three-fold increase in colic,(108) more crying and fussy 
behaviour,(109) increased rates of failure to thrive(22) and Sudden Infant Death Syndrome 
(SIDS).(23) Mothers who are depressed are less responsive to their baby’s cues,(110, 111) and 
babies of these mothers are less receptive to their mothers,(102) both of which can lead to 
the onset of attachment problems that can affect the entire family. 
Children of mothers depressed in pregnancy are more likely to have behavioural, 
psychological, and emotional problems such as depression,(112, 113) as well as growth and 
developmental problems,(113, 114) for example autism.(26) There is also evidence of lower 
IQ and a decreased ability to cope with stress and to perform adequately in neuromotor 
tests after exposure to stress and anxiety in utero.(42, 100, 115, 116) Children of anxious 
mothers have been found to have twice the risk of attention deficit/hyperactivity 
symptoms (5% to 10%), and up to 15% greater for the most anxious mothers compared 
with non-anxious women.(117) Adult males and females born to depressed women are 1.5 
times more likely to have engaged in criminal activity(118) and females of mothers who 
experienced depression in pregnancy were found to have more major depressive illness 
later in life.(119) 
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2.8 Interventions 
Interpersonal therapy, support groups, Electro-convulsive therapy (ECT), light 
therapy, and medications, especially when used in combination, can be effective 
interventions for depression.(42, 120-123) Support, particularly of the partner, has been shown 
to be effective for the prevention and recovery from Postpartum Depression (PPD),(124, 
125) however, there is a dearth of literature about effective interventions for antenatal 
depression. 
Elliott et al. studied high-risk women who attended depression support groups in 
pregnancy and confirmed that they are less likely to develop PPD than those who did not 
attend support groups.(126) However, 213 pregnant women who were randomly assigned 
to either an intervention group or no intervention group did not show any difference in 
depression status at 6, 12, or 24 weeks postpartum. Attendance of the intervention group 
was only 31%; it was highest antenatally (41%) and lowest at 6 weeks postpartum 
(24%).(122)  
Treatment of antenatal depression, as with any illness during pregnancy, often 
involves balancing the benefits of treating the mother with the potential of risk to the 
fetus. This is particularly true when treatment involves medications.  
Recent reports from Health Canada support the apprehension that women and 
caregivers may feel about antidepressant use. In December 2005, they warned of 
increased risk of congenital heart malformations with use of Paroxetine (Paxil). In 2006, a 
study of 377 women using Selective Serotonin Reuptake Inhibitors (SSRI) after 20 weeks 
gestation, found that babies had a 6-fold increase of Persistent Pulmonary Hypertension 
of the Newborn, a rare but potentially fatal lung disease.(127) Citalopram, another SSRI, 
was studied in 108 women at the Hospital for Sick Children in Toronto, Canada. 
Researchers found a four-fold increase of neonatal adaptation syndrome requiring 
admission to the neonatal intensive care unit.(128) A Canadian study revealed no 
teratogenic effects or toxicity in 150 babies whose mothers had used the antidepressant 
Venlaflaxine.(129) 
Maternal antidepressant use in pregnancy has been associated with lower Apgar 
scores, increased respiratory distress, hypoglycemia, preterm delivery, prolonged 
hospitalizations, and neonatal withdrawal, abstinence, or adaptation syndrome.(130, 131) 
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Neonatal withdrawal can include jitteriness, irritability, respiratory and feeding problems, 
and convulsions. These problems are reportedly transitory (up to 48 hours) and 
manageable with no long-term sequelae identified to date.(132) It might also be that these 
symptoms are a result of the effects of the depression, other medications used before and 
during birth, or the delivery itself.(133)  
For a woman who has conceived while taking antidepressants, she can be 
reassured that more than 50% of pregnancies are unplanned and many women do become 
pregnant while taking such drugs.(134) Pregnancy may not be a good time to either switch 
or discontinue antidepressant medications as a woman who is getting good relief of 
symptoms with medication may relapse and be difficult to re-stabilize.(135) Some 
physicians suggest that antidepressant doses should be tapered prior to delivery to 
minimize potential withdrawal in the newborn, while at the same time attempting to avert 
maternal depression.(42, 136) 
The Centre for Evaluation to Risks on Human Reproduction extensively reviewed 
the effects of Fluoxetine (Prozac), a common antidepressant in pregnancy.(130, 137) The 
Centre concurred with the Canadian Pediatric Association that the risk of antidepressant 
use before birth outweighs the impact of untreated maternal depression on the fetus.(137, 
138) 
2.9 Summary 
Depression is an important public, mental, and population health concern. 
Untreated, antenatal depression can be harmful to the health of the pregnant woman, her 
developing fetus, and growing family. This is especially worrisome when there is 
increasing evidence that negative influences on the fetal environment can compromise the 
health of an individual throughout his or her lifespan. 
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CHAPTER 3 
THEORETICAL PERSPECTIVES 
The purpose of this chapter is to describe the two underlying theoretical 
perspectives that have guided this research. The first perspective is a prevention model, 
which underlies the foundational rationale and implications of the study. The second 
perspective involves a population health approach, which provides the structure for data 
collection and interpretation.  
3.1 Prevention Approach 
Epidemiologic studies such as this one, which focus on subpopulations, can help 
us to identify factors that put people at risk for disease.(139)  There are three levels of 
prevention to consider: primary, secondary, and tertiary.(139)  
The goal of primary prevention is to identify risk factors for a disease before it has 
occurred, and to intervene on these risk factors to prevent the disease from affecting 
people.(139) Primary prevention is the essence of community health practice: it enhances 
quality of life, and decreases morbidity, mortality, and overall health care costs.(140) 
Secondary prevention identifies those people who already have disease. 
Secondary prevention can prevent mortality and complications of the disease through 
early detection (e.g., screening), intervention, and treatment. Interventions that have 
focused on modifying these risk factors include prevention on both a primary and a 
secondary level.(139) Tertiary prevention often occurs after the disease has occurred and 
has had an impact on the person’s level of health. It includes interventions that are 
rehabilitative, with a goal to help the person attain a new level of wellness as well as 
ongoing detection.(139, 140)   
In the model of levels of prevention for antenatal depression proposed in this 
thesis, shown in Figure 3.1, the fetus is seen nested entirely within its mother, developing 
its own biology with the genetic endowment it has received from both parents. The 
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uterine environment also directly affects the growing fetus, and is under the influence of 
the mother’s health status.  
Primary prevention for the fetus as conceptualized in this model involves 
prevention of antenatal depression through the identification of risk factors in the mother, 
and the prevention of the effects of antenatal depression on the fetus should the mother 
become depressed. Primary prevention also requires maternal interventions at the 
primary, secondary, and tertiary levels. 
Prenatal and obstetrical care usually follows a biomedical model of assessments 
and interventions that focus primarily on the physical well-being of the mother and 
baby.(52)  However, secondary prevention of antenatal depression may also thwart the 
effects of antenatal depression such as complications of pregnancy that affect both the 
mother and the fetus like Caesarean section, operative and preterm delivery, and 
gestational hypertension, and worsening depressions in the mother.  
Primary and secondary intervention at the maternal level involves universal 
screening and identification of the psychological, obstetrical/biological, 
sociodemographic, and behavioural determinants of antenatal depression. If women are 
found to be depressed they receive the appropriate treatment (pharmacologic, 
psychological or both) to reduce the depression, but also there must be a concerted effort 
to ameliorate the associated sociodemographic, obstetrical/biological, psychological, and 
behavioural determinants associated with depression. 
Tertiary prevention involves policy and programming that promotes ongoing 
screening and accessible treatment of antenatal depression to improve the mental health 
of the mother. It also needs interventions that lead to a policy and programs that promote 
the identification, treatment, and rehabilitation from antenatal depression. At a societal 
level, tertiary prevention will decrease the inequities in health determinants 
(sociodemographic, obstetrical/biological, psychological, and behavioural) that contribute 
to antenatal depression at an individual, cultural, and community level.(139) 
All of the levels of prevention work collectively to improve the chances for 
optimal health of the developing fetus, which will in turn promote the prevention of 
future social and health problems in the growing child into adulthood.  
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Figure 3.1 Levels of Prevention: Antenatal depression and the fetus  
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3.2 Population Health Approach 
While disease prevention has traditionally included the levels of prevention 
focused on individual people, a population health approach is a more suitable framework 
for primary prevention within the community.(140) The purpose of population health is not 
only to improve and maintain the health of the population, but also to decrease the 
inequities in health status among different groups of people and to improve the quality of 
life for the population as a whole over the lifespan.(140) It addresses the determinants of 
health and highlights the assessment of health status inequalities, the interaction between 
and among determinants, evidence-informed decisions, and the root causes of illness.(140, 
141)  
The World Health Organization (WHO) defines disability as the number of Years 
Lived with Disability (YLDs), and reports that it is a key factor in determining the overall 
health status of a population. In 2000, the WHO ranked depression as the fourth greatest 
contributor to disability worldwide, responsible for 3.7% of total global disease burden as 
determined by the Disability Adjusted Life Years (DALYs-sum of years of potential life 
lost due to premature mortality and the years of productive life lost due to disability) in 
both sexes in the 15-44 age group.(33) However, depression, according to the WHO, is 
already the number one cause of disability in women worldwide.(142)  
Health determinants are factors that work together to influence health beyond the 
usual health services and illness to include a person’s social, economic, and other life 
circumstances.(143)  The determinants that have previously been used to try to explain 
women’s susceptibility for depression include: biology/genetics, environment, 
psychological disposition, and socioeconomic status.(39) The WHO states that the 
identification and modification of the social factors that influence women’s mental health 
offers the possibility of primary prevention of depression.(144) 
 Population health requires significant attention to multiple determinants of 
health.(145) A population health approach to depression research and services focuses 
attention on root causes (e.g., poverty) and solutions. Population health also includes 
policies and strategies, which deal with the wider influences of social inequalities such as 
income distribution and education on health. This practice may have more impact on 
health than just relying on the usual biomedical approaches, which have traditionally had 
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a narrower focus on health of the individual, through means like changing unhealthy 
behaviours and attending treatment.(141)  
Population health is a fitting approach to the study of depression during 
pregnancy, particularly in high-risk women, but the literature offers a mixed and 
sometimes contradictory account of the factors associated with antenatal depression. For 
this study, a population health approach has been used to examine the depression status 
and the risk factors and correlates of depression in pregnant women.  
The population health approach shown in Figure 3.2, recognizes that there are 
determinants of health that work together at multiple levels and involvement to affect 
health status of the mother and consequently the well-being of the fetus and future adult. 
The anticipated determinants of antenatal depression are grouped and named as 
sociodemographic, obstetrical/biological, psychosocial, and behavioural. Each 
determinant is discussed in more detail, in relation to its role in this study, in Section 
4.5.3 of Chapter 4.  
These determinants are affected by the mother’s genetics/biology, life 
experiences, health history, and opportunities for healthy living. Some of these are at the 
individual level while others are at the community, family, society, and societal levels. 
For example, a single mother of three young children living in an inner-city 
neighbourhood may not have easy access to medical facilities, which may have a negative 
effect on her ability to get adequate prenatal care and decreases the chances for detecting 
problems such as anxiety and depression, and which may lead to less than optimal 
pregnancy outcomes. There is no routine assessment for depression in our region at this 
time. While these factors are important to the health of the mother and the fetus, they are 
not the focus of the research in this thesis; rather it focuses on the measurable 
determinants of antenatal depression at a more immediate level. 
3.3 Summary 
This thesis is guided by the perspective, premise, and hope that secondary 
prevention for women who are depressed in pregnancy will lead to early intervention on 
the mother, which will in turn exert primary prevention of disease, disability, and risk 
factors in the fetus, reducing effects of maternal depression of the child into adulthood. 
Using a population health approach to data collection and interpretation will lead to 
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increased knowledge about the prevalence and determinants associated with antenatal 
depression that will further our ability to promote levels of prevention through a more 
comprehensive approach to research of depression in pregnancy. 
 
Figure 3.2 Determinants of antenatal depression and the fetus 
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CHAPTER 4 
METHODOLOGY 
This chapter describes the study design, the study population and sites, the 
preparation for the study, working within the health care system, staff training, 
recruitment, and inclusion and exclusion criteria. Then the chapter details data collection, 
questionnaire development, outcome variable, independent variables, sample size, and 
ethical considerations. Next, it describes the data preparation, methods for analysis of the 
data, and ends with the limitations of the study. 
4.1 Study Design 
This thesis included the first cross-sectional portion of a larger, longitudinal, 
epidemiological study of antenatal and postnatal depression in high-risk women in 
Saskatoon. The ongoing study was a cohort of 402 high-risk women who were 
interviewed in early pregnancy, again later in the pregnancy, and once after their babies 
were born. This cross-sectional portion was selected for this thesis due to the length of 
time before the final postpartum interview would have been completed and the 
implications for finishing the thesis.  
4.2 Study Population 
All study participants were clients of either the Healthy Mother Healthy Baby 
Program of the Saskatoon Health Region or the Westside Clinic of the Saskatoon 
Community Clinic in Saskatoon, Canada. 
4.2.1 Healthy Mother Healthy Baby Program 
The Healthy Mother Healthy Baby (HMHB) program of the Saskatoon Health 
Region began in 1983. It is a prenatal program designed to meet the needs of “hard to 
reach” pregnant women who are unlikely to engage in other prenatal services. It strives to 
promote optimal pregnancy outcomes and healthy lifestyle choices by providing support 
and education to approximately 500 women a year. While the program was originally 
intended for Aboriginal women, only 65% of women who attend now are either First 
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Nations or Métis. HMHB offers community-level interventions that focus on the social 
and financial stressors during pregnancy.  
Service is provided in partnership with a variety of local programs such as Food 
for Thought (a cooking program that is part of the Canada Prenatal Nutrition Program), 
the Westside Clinic (discussed in detail in 4.2.2), KidsFirst (a program for addicted 
mothers within selected high-risk geographical areas of Saskatchewan), Healthy and 
Home (an early discharge program for new mothers), Saskatoon School Board (for 
women who are pregnant and attending school), Addiction Services (for women who are 
receiving services for addiction problems), the Salvation Army (a residential program, 
which is offered for pregnant teens and women who are unable to remain in their homes), 
Open Door Society (all new immigrants who are pregnant are offered an assessment with 
HMHB), and Social Services (the majority of women in HMHB are presently on social 
service assistance).(146) 
Prenatal Outreach Workers, Maternal Child Registered Nurses, and a Nutritionist 
function as a team to provide individualized counselling in a home visit, outreach 
program. Interventions focus on alleviating adverse issues related to low-income status, 
poor nutrition, and unstable relationships and living situations, as well as reducing or 
eliminating alcohol, tobacco, and other substance abuse. Clients receive free prenatal 
vitamins, iron, Lactaid, milk coupons, and assistance with transportation to medical visits 
and prenatal classes. The program provides a variety of prenatal classes, such as single 
parent classes, expert information (e.g., legal), and special hospital tours for immigrant 
women. HMHB also offers a “Collegiate Program”, which offers service to all pregnant 
women who are attending high-school or educational upgrade programs in Saskatoon.(146) 
The majority of women call HMHB directly on the recommendation of friends or 
family members, although some are referred by other caregivers. Women are followed 
throughout pregnancy through home or school visits. Every client gets at least one 
postpartum visit by a nurse in the first few weeks after the baby is born. Women with 
ongoing needs are referred to other community agencies before being discharged from the 
program.(146) 
The program uses broad risk categories to define eligibility for participation in 
HMHB. Following assessment by the nurse, the woman may be categorized as “low, 
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medium, or high risk” and is invited to participate in HMHB if she meets one of the 
following three risk categories: 
• Low risk: Women with a need for information about pregnancy, nutrition, 
or with financial problems. They do not exhibit harmful lifestyle 
behaviours. 
• Medium risk: Women who have recently decreased or quit harmful 
lifestyle behaviours such as tobacco or drug use. The woman is at risk for 
resuming the harmful behaviours under stress. 
• High-risk: These are women with multiple stressors and who continue to 
participate in harmful lifestyle behaviours despite having received 
education about their effects on the fetus. 
 
Women who do not meet these risk categories or who meet them but do not wish 
to participate in HMHB are directed to their physician, to prenatal classes, or to other 
organizations to get the assistance that they require.(147) 
4.2.2 Westside Clinic 
The Westside Clinic (WC) is part of the Saskatoon Community Clinic. The 
Saskatoon Community Clinic is a health care co-operative founded in 1962. As an 
organization, they are concerned with: 
• the effects of poverty on health 
• support for publicly-funded health care 
• advocacy for the community clinic model of primary health care 
• environmental issues 
• support for programs to improve the lives of people who are not the 
greatest risk, including children, youth, Aboriginals, disabled persons, and 
seniors.(148) 
 
WC is a separate store-front clinic situated in an inner-city area of Saskatoon. This 
location is convenient for women to drop-in or for ease of access by public transit. They 
do not have a policy that defines risk per se: rather all the clients they attract frequently 
experience socioeconomic stressors and addiction problems that put their health and the 
health of their baby at risk. WC provides medical care and psychosocial support to 60-80 
pregnant women a year. All women who attend the WC are encouraged to participate in 
the HMHB program, but some women are struggling with addiction and other social 
problems that put them at very high risk and often they choose not to engage in any 
formal programming. WC offers prenatal clinics, which are open every Thursday 
afternoon for women to drop-in and ease their access to care.(148) 
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4.3 Preparation for the Study 
4.3.1 Pilot study 
Pilot studies are used to develop and test study tools and procedures and produce 
preliminary data.(149) Pilot studies can convince funding agencies that the main study is 
feasible and worth funding, and engage stakeholders in support of the study.(149) A pilot 
study of this project was conducted within HMHB in March and April of 2004. The 
findings were published in the Journal of Obstetrics, Gynecology, and Neonatal Nursing 
in July 2006.(82)   
4.3.2 Working within the health care system 
Once we determined that this study would take place, we formed an Antenatal 
Depression Advisory Group. This group consisted of administrators, educators, and 
clinicians involved in mental health, primary care, and women’s health within the health 
region, including HMHB and WC. The group met every few months before the pilot 
study and throughout the study. A flow chart of available resources and the referral 
process was developed by the student and refined by the group (Appendix B). Mental 
Health Services within the health region agreed to provide immediate support and up to 
three counselling sessions to the women identified who screened positive for potential 
depression in the study. The WC had the resources to provide the support, counselling, 
and medical treatment to their clients who screened positive for depression in the study.  
The Obstetrical Operations Committee for the Saskatoon Health Region was 
given overview of the study. Family physicians in the region were made aware of the 
goals and the commencement of the study at their monthly city-wide meeting in October 
2004. They were also shown a copy of the referral form that they would receive if their 
client screened positively for depressive symptoms during the study so that they could 
further investigate and start any treatment that may be necessary. This form would be sent 
to the family physician of a woman who screened positive for depression with her 
permission (Appendix C). Women who were clients of WC were assessed by 
practitioners at that clinic. 
The HMHB staff wanted to have information about depression and other feelings 
encountered by pregnant women to give to their clients. A booklet about “Feelings in 
Pregnancy and Motherhood” was developed for the women and their families. The staff 
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edited and approved the content and the style of the booklet. It was available for all 
potential participants whether they choose to join the study or not (Appendix D). 
4.4 Recruitment 
Recruitment commenced in October of 2004 and continued to August 2006. At 
HMHB, the nurse introduced the purpose of the study: “to improve our understanding of 
feelings during pregnancy and motherhood” and described the commitment needed by the 
woman for participation in the larger study. This included an interview to complete two 
short questionnaires on three different occasions. Women attending the WC were 
similarly recruited by the nurse in charge during visits at the prenatal clinic regularly held 
on Thursday afternoons.  
4.4.1 Inclusion and exclusion criteria  
All participants of HMHB or WC who spoke English were invited to participate in 
the study. Originally, only women under 20 weeks gestation were recruited to allow for 
the two data collection times during pregnancy. The average gestation of women in the 
pilot study was 17 weeks, with women at various stages in their pregnancy, and not 
necessarily at their first visit, and we were able to recruit 78% of those women. 
Therefore, recruiting women less than 20 weeks seemed feasible; however, within a few 
months of starting this larger study, both sites reported that many women were being 
excluded from the study because they were beyond this cut-off gestation period. Research 
has shown that women who are depressed present for prenatal care later in their 
pregnancies.(10) Therefore, to ensure that the data represented the most accurate reflection 
of this group of women, the criterion was changed to include all women at their first 
prenatal visit, no matter what their gestation was at the time of the first visit.  
4.5 Data Collection  
Staff at HMHB had participated in other research studies. In their experience, 
women in the program and their partners were becoming increasingly suspicious of 
strangers coming into their homes to collect information. This was especially true when 
the information was of a personal nature such as the extent of working outside the home, 
family violence, substance abuse, or any issues that may be reported to authorities, and 
which could lead to problems with social services such as apprehension of the baby. 
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Consequently, the manager and staff believed that they would be more successful in 
recruitment and data gathering than outside researchers would be.  
The same philosophy about data collection for research purposes exists at the WC. 
I offered to be present to collect the data at each of the regular weekly prenatal clinics, 
but this was declined by WC. Instead, like HMHB, they chose to recruit and to collect the 
data themselves. There was no remuneration for either site for data collection or to the 
women for their participation in the study. Therefore, data collection was integrated into 
the regular work of the staff of HMHB and the WC, with the study questions and tools 
kept to a minimum.  
In the eight months preceding the commencement of the study, I met with the staff 
at both sites, to incorporate study questions into the intake tools and procedures. The staff 
at HMHB had participated in the Pilot Study and had received some training in how to 
administer and score the depression screen tool.  
To prepare for this study, a four-hour in-service was developed and presented to 
all staff both by myself and by a nurse therapist who specializes in the anxiety and mood 
disorders, particularly postpartum depression. The in-service included information about 
the signs and symptoms, aetiology, effects, and treatment of antenatal depression, and 
how to manage client issues that may arise from any of the items on the study tools e.g., 
identification of self-harm thoughts. It also incorporated instruction on the origins, 
administration, and scoring of the depression screen used in the study. The specifics of 
the study were discussed and a study protocol was developed to assist staff in data 
collection (Appendix E). The protocol was subsequently changed to include all women at 
their first visit, once the study was underway. I attended staff meetings, visited both 
offices, and kept in touch via telephone and email contact throughout the study. 
4.5.1 Questionnaire development 
The intake and discharge databases used by HMHB were extensively revised with 
the staff between May 2004 and September 2004. Questions for use in the study were 
incorporated as much as possible into existing documents and were tested with staff and 
clients over six months. Some questions about exercise, alcohol, tobacco, and drug use, 
which were not of interest to the program, were put on a supplemental sheet for study 
purposes (Appendix F). 
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WC staff used the provincial prenatal form as their only data collection tool for 
pregnant women. To standardize data collection between the two programs, items from 
the HMHB intake database required for the study were put on separate sheets for the 
women attending the WC (Appendix G). 
Some items on the questionnaire were single item questions; this was done to 
facilitate data collection during routine visits with clients, many of whom may not have 
completed high-school. The questions were tested and retested with clients by the staff 
and the researcher and appeared to have face validity.(150) To improve the reliability of 
these questions for analysis, new variables were created by summing those items that 
were thought to measure a specific construct. These new variables (i.e., support, stressors) 
were tested for how well they measured the particular construct using the Cronbach’s 
alpha coefficient. The generally agreed limit for the Cronbach’s alpha coefficient is 0.70, 
with a lower limit of 0.60 for preliminary steps in research.(151) 
4.5.2 Outcome variable 
The outcome variable or variable of interest for this study was depression in 
pregnancy. The most commonly used screening tools for depression in the general 
population include the Beck Depression Inventory (BDI), Brief Symptom Inventory 
(BSI), Centre for Epidemiological Studies - Depression (CES-D) scale, and Research 
Diagnostic Criteria (RDC).(72) The Edinburgh Postnatal Depression Scale (EPDS)(50) is a 
tool developed in 1987 to screen for depression in postnatal women but was validated for 
use in pregnant women shortly after.(152) The EPDS is different from depression tools 
used in other populations as it removes the physical symptoms of depression associated 
with pregnancy and postpartum.(50)  
The EPDS is the most widely used and translated screening tool for depression in 
childbearing worldwide.(43) Validation studies show that the EPDS has very good 
psychometric properties when compared to the most commonly used depression 
screening tools such as the Research Diagnostic Criteria (RDC), the Beck Depression 
Inventory (BDI) or the Center for Epidemiologic Studies Depression Scale (CES-D). 
Appendix H summarizes some of the validation studies and psychometric properties of 
the EPDS; as it shows, the sensitivity ranges from 73 to 100%, specificity from 68 to 
96%, and the positive predictive value 56 to 73% in antenatal and postpartum women.(43, 
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72, 153) The EPDS was validated against the SCID (Structured Clinical Interview for DSM-
IV Axis I disorders) in 110 Saskatchewan Aboriginal postpartum women in 2004 and was 
shown to have very good sensitivity (94%) and specificity (86%).(154)  
The EPDS was chosen for this study because of its ease of use, extensive 
validation, non-commercial availability, feedback from the pilot study, and the desire of 
the participating organizations for an ongoing process for screening following 
participation in the study. The EPDS is meant to be self-administered. It includes 10 
items with a Likert scale of responses scored from 0-3, to a maximum score of 30. The 
EPDS is available non-commercially. As the title of the EPDS contains the term 
“depression”, to avoid any potential bias of the woman’s responses it was renamed 
“Feelings in Pregnancy and Motherhood” for use in this study (Appendix I). The tool 
takes less than 10 minutes to complete and score (Appendix J). 
The EPDS has come under criticism for its sole reliance on self-reported items to 
detect depression rather than using the tool in conjunction with clinical interviews.(20) 
This is a valid criticism, but one that is equally applicable to other tools commonly used 
in large epidemiological studies that rely on self-reported items for measuring depression.  
The EPDS may not measure a single expression of mood or depression. A 
depression subscale (items 1, 2, and 8) and an anxiety subscale (items 3, 4, 5) have been 
identified in the EPDS in women in pregnant and postpartum women.(155), (156)  The 
validity of the EPDS as a tool to identify anxiety was affirmed by Stuart et al. who found 
a strong correlation between the State Anxiety Scale of the State-Trait Anxiety Inventory 
and the EPDS (r = .73 at 14 weeks postpartum, r = .82 at 30 weeks postpartum, 
n=107).(157) Brouwers et al. also tested the validity of the EPDS for measuring anxiety 
and depression,(155) and they confirmed the presence and validity of the subscales but 
found the overall EPDS most accurately measured both depression and anxiety.  
A single item, number 10, on the EPDS asks about thoughts of self-harm. Some 
people have questioned the reliability of the single item self-harm question in the EPDS 
to accurately detect suicide rather than other self-harm activities such as cutting or 
anorexia; however, Levey et al. compared sensitivity of the EPDS, Beck Depression 
Inventory, and the Hamilton Rating Scale for Depression and found that the EPDS was 
the most sensitive of the three for detecting suicidal thoughts.(81)   
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An EPDS score of 10 or more (>10) represents minor depression(158, 159) and a cut-
off score of 13 or more (>13) has been validated and recommended for detecting major 
depression in pregnancy(152) and is used most often to report the prevalence of major 
depression in antenatal and postpartum women in the literature.(6, 67) Thus, a score of >13 
was used to determine and report the prevalence of major depression in this study. All 
women who score at or above this cut-off were offered a referral to their physician for 
further assessment or to community agencies for supportive services (Appendix C). 
Therefore, it was essential to decrease the potential of women falsely screened as 
depressed. A higher cut-off may reduce possible overload on the health system, but it 
must be acknowledged that some women with depression may be missed through this 
process. Consequently, if staff were concerned about any aspect of the woman’s mental 
health they were encouraged to use their professional judgment and refer clients for 
medical assessment beyond the criteria established in the screening process, particularly 
those women who may have responded positively to the question about self-harm 
thoughts. 
In the analysis for this study, the EPDS was used as a continuous variable. It was 
also dichotomized into two separate derived variables: a) EPDS scores of greater or equal 
to 10 were used for identifying minor depression and b) EPDS scores of greater or equal 
to 13 for major depression. 
4.5.3 Independent variables: Determinants of antenatal depression 
4.5.3.1 Sociodemographic determinants 
Age: Research confirms a relationship between younger age and increased risk for 
depression, especially for those still living with their parents.(13) Johanson et al. studied 
417 women aged 15-41 (mean 24.6 years, SD 5), and they found a significant relationship 
between young age and depression in the postpartum but not in the antenatal women.(13) 
Age (years) was treated as both a continuous and a categorical variable (<21 and >21) in 
the analysis.  
Marital Status: Blazer reports that women who have never been married 
experience less depression than women who were separated, divorced, or widowed.(17)  It 
is unknown how many of these women were pregnant or postpartum. However, lone 
parenthood has been associated with a two-fold increase in depression, and single status 
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has been linked with antenatal depression.(6, 7, 67, 160, 161) Hobfall identified single status as 
the only indicator of antenatal depression in his study of high-risk women.(12) Single 
mothers access mental health services more often, experience more economic and social 
disadvantage, and were twice as likely to have suffered depression in the past year as 
married women.(7, 162)  Women were categorized as non-partnered for the purposes of this 
study if they were single, divorced, or widowed and partnered if they were married or in a 
common-law relationship.  
Ethnicity: In two studies of antenatal depression in high-risk women, minority 
status (Black) was associated with depression.(6, 12) On the other hand, Da-Silva was 
unable to establish a relationship between ethnicity and depression in pregnancy.(6) The 
birth rate to Aboriginal women is approximately 2.7 per woman compared to 1.6 per 
woman in the entire population of women in Saskatchewan.(163)  
Overall, Aboriginal people are at higher risk of depression.(1) This was confirmed 
by Muhajarine in 1994, who found that pregnant Aboriginal women were at double the 
risk for depression.(164) However, Beattie found similar rates of postpartum depression in 
Aboriginal women to non-Aboriginal women in the general population.(154) Given these 
differences in findings, it is important that future studies of depression in pregnancy also 
include a focus on Aboriginal women. Women who self-identified as First Nations or 
Métis were categorized as Aboriginal: all other women were identified as non-Aboriginal 
in this analysis. 
Education: Low education, particularly not graduating from grade 12, has been 
associated with depressive symptoms in inner-city pregnant women.(67) Education level 
was collected as a categorical variable. It was dichotomized to represent those women 
who had or who had not completed Grade 12. 
Income: Bolton et al., found poverty was the most important risk factor for the 
development of antenatal depression.(67) Low income has also been associated with 
postpartum depression.(165) Some authors believe that social selection or social drift 
(which occurs when people with mental health problems experience downward social 
mobility) is both an outcome and a predictor of low socioeconomic status(166, 167) and 
major depression.(17) Family income was assessed through five categories: under 
<$20,000 per year, $20,000 to $39,000 per year, $40,000-$60,000 per year, and >$60,000 
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per year, plus income assistance. This was dichotomized to <$20,000 and income 
assistance versus those earning over $20,000.  
4.5.3.2 Obstetrical/biological determinants  
Gestation: Preterm delivery (delivery at <37weeks gestation) has been associated 
with anxiety and depression in the mother.(91, 103, 168) Gestation (weeks) was recorded by 
staff or calculated from the expected due date and the date of the interview. 
Gravida or total number of pregnancies: Antenatal depression has been 
associated with first pregnancies and deliveries(6, 161) but other researchers conclude that 
increased parity is a factor in the development of depression in pregnancy,(14, 67, 169) 
particularly in younger women.(169) The actual number of pregnancies was recorded and 
used as both a continuous and a categorical variable in the analysis. 
Number of preterm pregnancies: Anxiety and depression in pregnancy have 
been associated with preterm delivery.(91, 168) The actual number of preterm deliveries was 
recorded and analyzed as a continuous and a categorical variable. 
Number of abortions: Antenatal depression has been linked to history of 
previous abortions.(19, 58) The actual number of abortions was recorded and analyzed as 
both a continuous and a categorical variable. 
Somatic and health complaints: Medical illness is highly associated with 
depression in the general population,(84) and particularly nausea and vomiting and 
headaches during pregnancy.(49)  Data on somatic and health complaint items were 
recorded as text data. This includes nausea and vomiting and headaches. These were 
simple yes or no responses. Each case was manually checked for somatic or health 
complaints and then developed a new variable which represented the somatic complaints 
as a numerical sum. These responses were also categorized: 0 complaints, 1 complaint, 2 
complaints, 3 complaints, and 4 or more complaints. Complaints of nausea and vomiting 
and headaches were treated as two separate dichotomous variables.  
Overall health today: There is widespread agreement that the question of “How 
would you rate your overall health today?” provides a useful summary of all aspects of 
health status.(170, 171) This item was treated as a categorical variable (Excellent, Very 
Good, Good, Fair, and Poor), but it was also dichotomized into Good (including 
Excellent, Very Good, and Good) and Poor (including Fair and Poor). 
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4.5.3.3 Psychological determinants  
Stressors: Life stress is associated with depression, especially in the antenatal 
period.(11, 172) Women were asked to put a √ (check mark) beside a list of specific sources 
of stress that they were presently experiencing. Potential responses included: Pregnancy, 
Partner, Money, Children, Family, Where I live, Health of my baby, Birth of my baby, 
Own health, Work, School, and Other stressor. The 12 items were summed into one 
composite variable by assigning 1 to each positive response to a stressor and 0 to the 
negative responses. The Cronbach’s alpha on these 12 items was high: 0.998. A single 
question about legal problems was added to the stressor items, and the alpha coefficient 
remained high at 0.991, which indicates strong support the items to be treated as a 
summary variable.(151) This summed variable was also categorized into: lowest (0-1 
stressors), middle (2-3 stressors), and highest (>4 stressors) numbers of stressors. This 
was determined by attempting to create categories of equal numbers of stressors. Each 
individual potential source of stress was also treated as a separate item in the analysis.  
Food Security: In a telephone study of 7,000 adults in Saskatchewan, food 
security issues were associated with increased levels of depression.(173) Two questions 
taken from the National Population Health Survey(174) asked about whether the woman’s 
family had enough food to eat or if she was worried that there would not be enough to eat 
because of a lack of money. Adding the food security items to the stressor scale increased 
the stressors to 15, decreased the Cronbach’s alpha to 0.975, and there was similarity in 
the stressor items about money and the food security items, so food security and stressors 
were treated separately. The responses to these two items were summed and then 
categorized into the low (negative response to both food security questions), middle (a 
positive response to one of the questions), and high amounts (positive response to both 
questions) of food insecurity. 
Support: Social support, especially from the partner, is perceived as essential to 
mental well-being in pregnancy.(67, 69, 161) This is particularly true for single mothers who 
may experience less contact with family and close friends.(7, 164) In a group of Australian 
women, lack of social support was associated with late prenatal care and depression, with 
women in the low support group twice as likely to have high levels of depression.(175)  
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Participants were asked whether they have someone from whom they received 
emotional support and, if so, the sources of that emotional support (partner, mother, 
friend, relative, or other), who gives them the most support, and if they can count on that 
person for support no matter what. The possible sources of support were added up to 
create a summary variable. The Cronbach’s alpha coefficient for these items was 0.915. 
The variable was divided into four types by attempting to develop equal categories: no 
support (0 support), low support (1 support), medium support (2 supports), and high 
support (3 or more supports). The items were also treated as specific sources of support: 
partner, mother, friend, female relative, and other.  
The responses to the questions about whether the woman was seeing a counsellor 
now or in the past were added to the summed support variable. The addition lessened the 
Cronbach’s alpha coefficient and decreased the number of available cases for analysis so 
they were left off the summary support variable. 
Relationship: Marital discord has been found to be a predisposing factor for 
PPD.(176) Therefore, women were asked: “Are you in a relationship now?” and “Are you 
satisfied with the relationship?” Fewer women answered this question than about their 
marital status and some women would check a negative response to the first part of the 
question (e.g., no relationship now) and then responded positively to the second part. 
Therefore, the question about marital status was used to represent the relationship status.  
Abuse: Depression has been shown to be both a predictor and an outcome of 
family violence, particularly during pregnancy.(69, 177-181) In a study of family violence in 
1,491 pregnant women, depression was highly correlated with abuse.(8) Yet, Morris-Rush 
et al. found no association between family violence and postpartum depression in a high-
risk inner-city population.(165)  
Participants were asked to respond either yes or no, if they had experienced 
specific acts of abuse against them: physical (hit, slap, restrained, punch, pinch, kick, beat 
you), emotional (yell, belittle, berate, blame, neglect), and sexual abuse (touched against 
their will, rape). These three items were combined into one summary variable of history 
of abuse. The Cronbach’s alpha coefficient on these items was only 0.681. Given the loss 
in the Cronbach’s value, they were used as separate categorical variables and not summed 
to one single variable. 
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History of depression: A history of depression is often associated with future 
depressive episodes, especially for postpartum depression,(182) but the research supporting 
a relationship between history of depression and antenatal depression is contradictory.(67, 
161, 183) This variable consisted of self-reported questions about the woman’s history of 
depression, and specifically antenatal and/or postnatal depression. An attempt was made 
to devise a summary variable measuring the construct “exposure to depression”. While 
these questions had a Cronbach’s Alpha greater than 0.7, including the history of 
antenatal and postnatal depression decreased the number of women available for other 
analyses: therefore, the history of depression variable was treated as a dichotomous item.  
Moods up and down: Increased fluctuation in moods is seen in people who are 
depressed.(184) Women were asked a single question about whether or not their moods 
went up or down.  
 4.5.3.4 Behavioural determinants 
Exercise: Exercise is associated with decreased depressive symptoms in the 
general population, in a dose-related amount.(185) Women were offered options about the 
frequency of exercise (e.g., 20 minutes of walking) in daily increments in the past week. 
The amount of exercise was used as a categorical variable: Every day, 2-3 times per 
week, occasionally, or never. 
Smoking: Smoking negatively affects the well-being of the woman, the outcomes 
of the pregnancy, and the health of the fetus.(15, 186) In a study of smoking and depression 
in pregnant women, Zhu reported that 12.9% of the women who never smoked were 
depressed, 25% of former smokers were depressed, and 37.5% of the women who 
currently smoked were depressed.(77)  
Participants were asked if they smoked, if they had ever smoked, the amount 
smoked per day in the last month, or if they had quit before or since becoming pregnant. 
Smoking was analyzed using these categories but was also recoded into three categories: 
never smoked, current smoking, or quit smoking (before or during pregnancy). The age at 
which smoking began was also asked. 
Alcohol use: Alcohol use and depressive symptoms exacerbate each other.(187) 
Women who use alcohol have increased acuity of depressive symptoms and are more 
likely to relapse, and are more resistant to treatment and more likely to commit 
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suicide.(187) The amount of alcohol use in pregnancy varies widely. Muhajarine reported 
overall alcohol consumption at some time during pregnancy to be 46%,(164) however, in a 
study of 2,100 pregnant women in a primary care setting, Marcus noted 10% of pregnant 
used alcohol.(56)  
Alcohol use was determined using questions that encompass the risk criteria for 
Fetal Alcohol Spectrum Disorder (FASD): i.e., drinking 5 or more drinks at one sitting 
(binge drinking), and drinking of 1- 2 drinks every day in the last month, or if they had 
quit using alcohol during or before pregnancy.(188) Women were also asked their age 
when they started drinking alcohol. Women could check (√) more than one category (e.g., 
occasional drink and binge drink). The variable was recoded into three categories of 
alcohol use: never used, current use, or quit use (before or during pregnancy).  
Drug use: Illicit drug use has been associated with depressive symptoms, 
particularly in pregnant adolescents.(76, 189-191) Participants were asked how often they had 
used illicit drugs such as cocaine, crystal meth., and marijuana in the past month or if they 
had quit during or before pregnancy, and the age that drug use began. The variable was 
recoded into three categories: never used, current use, or quit use (before or during 
pregnancy).  
Unplanned pregnancy: Unintentional pregnancy, when combined with low 
socioeconomic status or single status, appears to be significantly associated with 
depression.(78, 192-194) Women were asked if they had planned their pregnancy. This 
question had a yes or no choice for response but in the testing of the questions, women 
would often respond ‘sort of’, so this option was added and coded as a ‘yes’ for the 
analysis. 
4.6 Sample Size 
The sample size was calculated for the longitudinal study, which needed to 
account for potential attrition over the three data collection times. The sample size was 
calculated using the prevalence of depression, alcohol use, smoking, and drug use from 
the pilot study and other studies in high-risk women.(12, 82, 164) A sample size of 366 
women would be adequate to determine an expected prevalence of depression of 27% and 
other behavioural determinants in a longitudinal study and a sample of 302 in the cross-
sectional study, with power of 80%, and an expected 5% margin of error. Table 4.2 shows 
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estimated sample sizes required and the associated statistical power for each estimated 
sample size.  
 
Table 4.2 Power and sample size considerations  
Variable Expected 
prevalence 
(%) 
Margin of 
error (%) 
Estimated 
sample 
size 
Attrition 
20% 
Sample 
needed 
Depression 27 5 302 64 366 
Smoking 75 5 288 56 344 
Alcohol 13 5 264 52 316 
Drugs 18 5 254 50 304 
 
4.7 Ethical Considerations 
There may be concern about the potential for coercion of clients to participate 
when caregivers are involved in recruitment or data collection for research projects.(195) 
This would particularly be true for this group of vulnerable women who receive milk 
coupons and vitamins from the HMHB staff. The pilot study had a participation rate of 
78%, which indicates that some women felt free to refuse to participate without fear of 
repercussion. Recognizing that many of the potential participants would not have 
completed high-school, the consent was kept to one page and made as simple as possible. 
The consent also included the phone numbers of resources the woman could call if she 
had any concerns about her mental health (Appendix K).(82)  
It was anticipated that up to 30% of the participants could be less than 18 years of 
age. Accordingly, a Waiver for Parental Consent was developed to satisfy the 
requirements of the University Advisory Committee on Ethics in Behavioural Science, 
University of Saskatchewan (Appendix L).  
Ethical approval was obtained from the University Advisory Committee on Ethics 
in Behavioural Science, University of Saskatchewan, on September 10, 2004 (Appendix 
M). Saskatoon Health Region approved the research study on September 23, 2004 
(Appendix N). The Saskatoon Community Clinic gave verbal approval for the study in 
August of 2004.  
4.8 The Data  
Staff at both sites were concerned that some women who belong to both the 
HMHB program and who attend WC would complete the study questionnaires twice 
(within each program). To help avoid duplicate entries of data, each site kept a tally of 
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whether or not each woman in their program was or was not participating in the study. 
Women who participate in the HMHB program sign a consent stating their information 
may be shared with their family physician. Women who attend WC sign a consent 
agreeing for information to be exchanged with HMHB. To determine if there was 
doubling-up of participants at both sites, the secretaries from each program compared the 
WC list to see if women were participating at HMHB. Four women appeared to have 
completed the questionnaires at both sites; these women were included and coded in the 
study as WC clients.  
Each participant was given a unique identifying number at their site, and each 
page of the questionnaire reflected this identifying number and the site location. A new 
distinctive number was given within the study.  
4.8.1 Data entry 
Initially the data were entered into the Statistical Package for the Social Sciences 
(SPSS) 11.0 by the secretaries at HMHB and WC. These data were merged for analysis 
and the data entry was completed by me and two research assistants using SPSS 14.0. A 
supplemental form was developed for WC to transfer data from the Prenatal Sheet and 
birth record supplied by the hospital to the clinic (Appendix O). The intake sheets were 
photocopied by the secretary at HMHB and any identifying information was blackened 
out. Only the identifying number appeared on the data that was received for analysis.  
4.8.2 Data preparation 
Data were prepared for analysis using the process as outlined by Tabachnick and 
Fidell and Hair et al.(151, 196) First, data were double-checked against the original intake 
and data collection sheets for accuracy and erroneous entry; this data cleaning was done 
by two research assistants and me. Next, the data were assessed using descriptive 
statistics in SPSS for those data out of the possible range. If numbers did exist outside the 
range, the data were retrieved from the original sheets and corrected where possible or 
left as missing.  
The data were checked for missing values. As expected in this high-risk group of 
women, some variables had missing data. When missing values were found in continuous 
variables (e.g., age, EPDS), the missing values were imputed with the group mean to 
create a new variable. While this is the simplest option, it can lower the variability, which 
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in turn can bias results towards the null.(151) The variable with the imputed data were 
compared to the variable with the missing values using T-tests and Crosstabs. There were 
no statistical differences between the mean values of the variables with missing values 
and those with imputed values.  
Composite variables (e.g., stressors and support) were derived by summing items 
and using the Cronbach's alpha coefficient to see how well the factors of the EPDS 
measured a single construct.(151) The variables were checked for normality, kurtosis, and 
skewness. To facilitate reporting and interpretation of the data, no transformations were 
done to any of the variables. 
4.9. Approach to Analysis 
The method of analysis is reported by each research question to address the 
hypothesis outlined in Section 1.2.   
4.9.1 Question 1. What is the prevalence of antenatal depression in this 
sample of high-risk women and is this prevalence different from rates reported in the 
literature for comparable groups? 
Analysis: Following data preparation, descriptive statistics including, means, 
mode, median, standard deviations, and frequencies were assessed on each variable. The 
prevalence, incidence, and the 95% confidence intervals for major depression and minor 
depression were determined. Data between the two sites and participant and non-
participants were compared for differences by using Crosstabs or T-tests where 
appropriate. Post hoc analysis was done by logistic regression on the categories of the 
significant variables. A thorough review of the literature was done for comparison. 
4.9.2 Question 2. What sociodemographic, biological/obstetrical, 
psychological, and behavioural determinants are associated with antenatal depression in 
this group of high-risk women? 
Analysis: Descriptive and bivariate analyses were performed on each 
determinant. Chi-Square and T-tests were used to establish the associations between the 
dependent variable, EPDS (<13 or >13), and the various sociodemographic, 
biological/obstetrical, psychological, and behavioural determinants.  
Determinants, which had bivariate associations at p-value significance <0.25 were 
then entered into a logistic regression procedure to determine the final model for antenatal 
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depression in each of the determinants (sociodemographic, biological/obstetrical, 
psychological, and behavioural).(197) However, in the analysis for the final model, 
including all of the variables within each health determinant, using a significance level of 
<0.25, would have resulted in a large number of variables, greater than the 15-20 that are 
recommended.(151) Therefore, for the analysis of the final model, only those variables with 
a bivariate association significant at <0.10 were entered stepwise into the final logistic 
regression.  
The variables in each model within the sociodemographic, obstetrical/biological, 
psychological, and behavioural determinants and the final model for antenatal depression 
were tested for interaction. When there was no interaction present, the crude and adjusted 
odds ratio of determinants in the models were compared for potential confounding, and a 
10% difference was used to determine the presence of confounding. 
4.9.3 Question 3. What are the prevalence and determinants of antenatal 
depression in Aboriginal women compared to non-Aboriginal women, women 21 and 
under compared to women 21 and over, and non-partnered women compared to partnered 
women?  
Analysis: Similar analyses were done as in Question 2 for the different groups of 
women. 
 4.9.4 Question 4. Does the Edinburgh Postnatal Depression Scale develop 
into constituent measures of depression, how do they contribute to the overall score, and 
what are the determinants associated with these constituent measures in this sample of 
high-risk women? 
 Analysis: The mean was determined for each item of the EPDS. An exploratory 
factor analysis was performed to determine the different factors underlying the EPDS, 
without any prior restrictions on the number of factors.(151) A Varimax rotation was used 
to maximize the loadings of the factors.(151) Subscales were created by summing the 
individual items identified in the Factor Analysis. The Cronbach's alpha coefficient was 
used to determine the internal consistency reliability of the factors of the EPDS in its 
entirety and in the subscales.(151, 198) 
Linear regression was used to determine the associations between the 
determinants (p<0.25) and the anxiety, depression, and self-harm subscales in all women, 
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as well as in the Aboriginal and non-Aboriginal women, the partnered and non-partnered 
women, and the women over and under 21 years of age. 
4.9.5 Question 5. Are the constituent measures on the Edinburgh Postnatal 
Scale different for the subgroups of women (e.g., younger, Aboriginal, non-partnered)? 
Analysis: T-tests and the Mann-Whitney U-test were performed on the subscales 
to determine the differences between each of the two groups of women. The Cronbach’s 
alpha coefficient was performed on the subscales within the different groups of women to 
determine if the items retained their internal consistency in the different groups. 
4.10 Limitations 
The main limitations in this study focus on the nature of the participants, measures 
used, and cross-sectional study design.   
4.10.1 Participants 
The participants were voluntary clients of either the Healthy Mother Healthy Baby 
program or the Westside Clinic in Saskatoon. These women were considered high-risk in 
their life circumstance and behaviours, but it is accepted that the very high-risk women 
may not receive obstetrical care or participate in any prenatal programs, so they may not 
be represented in this data. Therefore, the results of this study are not generalizable to all 
pregnant women or all high-risk pregnant women. However, the findings may be of 
interest to other communities with pregnant women of similar risk or sociodemographic 
profiles, particularly in the prairie provinces and in the northern communities.  
It is acknowledged that people who participate in research related to psychiatric 
research are more likely to meet the criteria for mental disorders.(199, 200) On the other 
hand, severely depressed women may be too ill to want or be able to participate in a 
study.  
Women provided information to caregivers. This may have influenced their 
responses to the questions related to smoking, alcohol and drug use, income, and family 
violence. Pregnant women have been found to underestimate factors associated with their 
health history and data collected may be susceptible to recall bias.(201) 
Only English speaking participants were recruited into the study. However, 10% 
of the women who attend HMHB are new immigrants. The literature suggests that new 
immigrants to Canada have a lower rate of depression.(202) The EPDS is available for use 
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in a variety of languages and dialects, but the rest of the questions used in the study were 
only available in English. The program often uses translators, but staff said that the 
sensitive nature of some of the questions (abuse, depression) would make it difficult to 
ensure an accurate response from participants, so women who could not understand the 
EPDS or the questionnaires in English were not included. 
4.10.2 Study tools 
The Edinburgh Postnatal Depression Scale has been repeatedly validated in 
different settings and cultures, including Saskatchewan urban Aboriginal women.(43, 154) 
However, the EPDS was not validated in this particular population. 
The questionnaire used in the study was primarily for intake into the HMHB. It 
would have been ideal to have a number of validated scales for different determinants. 
For example tools that would screen for problem drinking (e.g., TWEAK or T-ACE),(203) 
or a support questionnaire (e.g., Maternity Social Support Scale),(175) or an anxiety scale 
(e.g., STAI-State-Trait Anxiety Inventory),(204) or an abuse screen (e.g., WAST - Woman 
Abuse Screening Tool)(205), would have given more in-depth information, but adding 
more questions was not feasible.  
There were no clinical interviews to confirm the diagnosis of depression in 
individual participants. Women at HMHB were referred to their family physician for 
further assessment, diagnosis, and possible treatment; however, there are over 60 
different physicians potentially involved in the care of this large number of women. Each 
doctor has their own unique practice styles and diagnosis criteria for diagnosis and 
treatment of depression. It was not possible within the constraints of this study to follow 
each participant out of the HMHB program to their personal physician. WC assessed and 
treated their own clients, but each practitioner uses individual approaches to diagnose and 
treat depression in their clients. 
4.10.3 Study design 
Cross-sectional studies are a type of observational study that are effective for 
determining the prevalence of disease in the total group and different subgroups and the 
association between variables, but the lack of a temporal relationship (other than recall) 
confines the ability to establish a causal relationship between the exposure and the onset 
of disease.(139) 
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A final, but important limitation was that data were primarily collected as part of 
intake to the respective programs rather than for a research study. Staff and management 
identified early on that collecting the data within the context of their regular job would be 
the best approach to data collection with such vulnerable and difficult to reach women. It 
became evident early in the study that there were competing interests between the clinical 
intake objectives of the study sites and data collection for the study. Staff illness, 
prolonged absences, and the eventual resignation of the program manager, as well as the 
relocation of the program to a new site, meant that there was less staff time available to 
do the additional work needed to introduce the study, get informed consent, administer, 
and score the EPDS, and collect the additional data on behaviours. Consequently, women 
who were eligible to be participants were not always recruited to the study, which may 
have lessened the prevalence and changed the associations in the bivariate analysis and 
logistic regression analysis.  
Staff collecting the data may have also led to errors in data collection and an 
increased susceptibility for information bias, particularly nondifferential 
misclassification.(139) Nondifferential misclassification occurs when there is a problem 
with data collection and classification of either cases or controls to the wrong category. 
The effect is to dilute or lessen the odds ratio towards 1.0 and decrease the likelihood of 
detecting an association if one exists.(139) 
4.11 Summary 
This study collected data about depression and determinants of depression in a 
high-risk socially vulnerable sample of pregnant women attending prenatal programs in 
Saskatoon. Study design and data collection was limited by the nature of the clients and 
the competing interests of the data collection sites. However, a large sample of women 
did participate in the study and they provided ample data for analysis.  
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CHAPTER 5 
RESULTS 
This chapter presents a description of the study participants and the 
sociodemographic, biological/obstetrical, psychosocial, and behavioural determinants 
associated with antenatal depression. Part One profiles the characteristics of the women in 
the study. It contains a comparison of sociodemographic variables between clients from 
the two sites: HMHB program and the WC. Limited data was also available from 83 
HMHB non-participants. Data from this group was compared to participants from the 
HMHB program. Unless otherwise indicated, a significance level of p<0.05 was used to 
determine statistical significance. Part Two addresses the questions posed in the thesis; it 
presents the prevalence, incidence, comparative, and analytic findings for the data.  
 
PART ONE 
5.1 Characteristics of the Participants 
As Figure 5.1 depicts, approximately 668 women from both study sites would 
have met the eligibility criteria and would have been potential participants during the 
study period.
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Figure 5.1 Study sample 
 
Total Deliveries for residents of the Saskatoon Health Region (SHR)
October 2004-August 2006 
~5035
Total women attending high-risk prenatal programs or services in SHR
Healthy Mother Healthy Baby Program = 558
Westside Community Clinic  ~110
Total = 668
Total Participants
Healthy Mother Healthy Baby Program = 329/558= 59%
Westside Community Clinic (and those attending both programs) = 75/110 = 75% 
(2 not used due to inadequate data)
Total=402
402/668~60% overall participation rate
Figure __
 
Data were collected and available for analysis for 402 women from the two sites. 
Some data were missing on individual women, but for inclusion in the analysis, the EPDS 
had to be completed. The sociodemographic, obstetrical/biological, psychological, and 
behavioural determinants are provided in detail in Tables 5.1 to 5.6.  
As Table 5.1 shows, the majority of women in this group were young (mean age 
22.8 + 5.2 years), non-partnered (56.6%), 63.7% have not graduated from high-school, 
85% were on social assistance or living on less than $20,000 a year, and two-thirds were 
of Aboriginal or Métis ancestry. Less than 4% live in a home that they own and more 
than 50% were planning to move. The numbers in each category may not total to 402, as 
there may be missing data for some of the items.  
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Table 5.1 Sociodemographic characteristics (n=402)*  
 n* % 
Age (years)   
      <20 125 31.1 
   20-24 161 40 
   25-29 61 15.2 
   30-34 43 10.7 
   35-39 11 2.7 
      >40 1 0.2 
Marital Status   
   Single 205 54.0 
   Common Law 126 33.5 
   Married 37  9.8 
   Separated/divorced/widowed 10  2.7 
Ethnicity   
   Aboriginal-Status 193 49.5 
   Aboriginal-Non Status 18  4.6 
   Métis 44 11.3 
   Caucasian 114 29.2 
   Immigrant 14  3.6 
   Other 7  1.8 
Education   
   <Grade 8 19  4.9 
   Grade 9-12 228 58.6 
   Completed grade 12 76 19.5 
   Some post secondary 41 10.5 
   Completed post secondary 24  6.2 
Income   
     Income Assistance 213 56.5 
     <$20,000 108 28.6 
      20,000-39,000 32 8.5 
      40,000-59,000 6 1.6 
      >60,000 1 0.3 
      Other 17 4.5 
* Totals do not always equal to 402 due to missing data 
 
Table 5.2 describes the obstetrical and biological determinants of the women. The 
average gestation of the pregnancy at the time of the assessment was 15.2 weeks 
(+ 6.5 weeks), with a range 4.5-35 weeks. Sixty percent of the women have already had 
one pregnancy, and the average number of pregnancies per woman was 2.6 + 2.03. 
Twenty-five percent of the women have experienced an abortion, but it was not known if 
these were induced or spontaneous. Most of the women reported their overall health as 
excellent, very good, or good (82.0%). Twenty percent of the women reported nausea and 
vomiting. 
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Table 5.2 Obstetrical/biological determinants  
 n % 
Total number of pregnancies  
                                                       1 160 39.5 
                                                       2  91 22.7 
                                                       3  52 13.0 
                                                       4  34   8.7 
                                                         5+  65   16.1 
Number of pregnancies to term  
                                                     0 235 58.6 
                                                     1 72 18.0 
                                                     2 43 10.7 
                                                     3 31   7.7 
                                                        4+ 20   4.9 
Number of preterm pregnancies  
                                                   0 384 95.8 
                                                   1 17  4.2 
Number of abortions  
                                                  0 296 73.8 
                                                  1 61 15.2 
                                                  2 26  6.5 
                                                  3 11  2.7 
                                                  4 7 1.7 
Number of living children   
                                                 0 190 47.4 
                                                 1 91 22.7 
                                                 2 51 12.7 
                                                 3 39  9.7 
                                                 4 16  4.0 
                                                   5+ 14 3.3 
Total number of somatic and health complaints    
                                                0 88 21.4 
                                                1 93 23.1 
                                                2 83 20.9 
                                                3 68 16.9 
                                                  4+ 72  17.9 
Nausea & Vomiting   
       Yes 81 20.5
Headaches 
      Yes 53 13.2
Overall health today   
      Excellent 31   8.5
      Very good 104 28.4
      Good 165 45.1
      Fair 48 13.1
      Poor 18   4.9
 
The cumulative stress score was an average of 2.26 + 1.79 stressors. As Table 5.3 
shows, most of the women experienced medium (2-3 stressors) to high levels of stressors 
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(4+ stressors). Almost 40% report money as a stressor. Over 30% report high food 
security problems. Almost half of women report low levels of support: the cumulative 
support score was 1.66 + 0.87 supports. Of the 43.4% of women who said they were 
married or in a common-law relationship, 64% reported their partner as a source of 
support, and 46.9% stated that their partner gave them the most support. For non-
partnered women, 31.6% received the most support from their mother. Over 90% of the 
women stated that they were able to count on the person who supported them the most no 
matter what happened to them. 
Fifty percent of the women had a history of physical abuse, 56% reported 
emotional abuse, and 36.6% reported sexual abuse. Forty-three percent of the women had 
a history of depression. Fifteen percent of participants reported that their mothers 
experienced a depression during or after pregnancy; however, 63% of women either did 
not respond or did not know about their mother’s obstetrical depression history. Of the 
women who have been pregnant before, 24.9% have experienced antenatal depression 
and 33.8% had postpartum depression. 
 
Table 5.3 Psychological determinants 
     n      % 
Stressor score  
   Lowest (0-1stressors) 161 40.0
   Middle (2-3 stressors) 135 33.6
   Highest (4+ stressors) 106 26.4
Specific sources of stress 
     No stressors right now 64 16.3
     Pregnancy 63 16.0
     Partner 108 27.5
     Money 157 39.9
     Children 58 14.5
     Family 78 19.8
     Where I live 64 16.3
     Health of my baby 59 15.0
     Birth of my baby 39 9.9
     Own health 34 8.7
     Work 42 10.7
     School 55 14.0
     Other 112 28.6
Food Security  
    Not have enough food to eat?                 Yes 120 34.7
    Worry that there would not be enough  
     to eat because of a lack of money?         Yes 
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44.1
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Table 5.3 Psychological determinants 
     n      % 
Food security  
   Lowest (negative response to both questions) 176 52.5
   Middle (positive response to one question) 55 16.4
   Highest (positive response to both questions) 104 31.0
Support score   
   No support 19 4.8
   Low  (1 support) 169 43.0
   Medium (2 support) 143 36.4
   High  (3+ supports) 62 15.8
Specific sources of support  
     Support in general 376 94.5
     partner 177 44.5
     mother 168 42.3
     friend 124 31.2
     female relative 111 27.5
     other (father, mother-in-law etc.) 81 20.5
Who gives most support? (# or % of positive response to each item) 
     Partner 103 25.6
     Mother 95 26.1
     Friend 38 10.4
     Female relative 56 15.4
     Other and combination of above 56 15.4
Can you count on that person no matter what? 
     Yes 328 91.9
Have you had counselling in past?   
     Yes   232 60.7
Are you in counselling now?   
     Yes    63 16.7
Are you in a relationship now?   
     Yes 284 75.8
Are you satisfied with the relationship? 
     Very satisfied 
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65.3
     Somewhat satisfied  77 29.7
     Not satisfied  13 5.0
Have you been physically abused?            
     Yes 187 49.9
Have you been emotionally abused?        
     Yes 210 56.1
Have you been sexually abused?            
     Yes 136 36.6
History of depression  
     Yes 167 43.5
In women who have had a pregnancy,   
    Previous antenatal depression 50 24.9
    Previous postnatal depression 70 33.8
Do your moods go up and down     
    Yes 185 50.7
Legal Problems      
    Yes 75  19.9
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Table 5.4 describes the behavioural determinants of health. Ninety percent of the 
women reported some level of physical activity. Fifty-five percent of the women reported 
smoking in the current pregnancy and 30% reported that they had quit either before or 
during the pregnancy. The number of women who stated that they presently use alcohol 
was 10.9%. However, women checked off (√) more than one category, as they were able 
to do (e.g., Occasional drink and 5+ drinks at one time), to try to capture different 
patterns of drinking-the woman who might occasionally drink but also have binge 
episodes that would potentially contribute to problems for the fetus such as Fetal Alcohol 
disorder. Some women reported that they were drinking a certain amount but also that 
they had quit, when this was the case, the women were categorized as having quit using 
alcohol. 
Women reported using drugs more often that alcohol (18.5% versus 10.9%). The 
average age of starting smoking was 13.4 + 2.9 years, with alcohol use starting at age 
14.7 + 2.7 years, and drug use beginning at age 15.1 + 3.2 years. The age of starting 
tobacco, alcohol, or drug use was not associated with depressive symptoms.  
 
Table 5.4 Behavioural determinants  
           n           % 
Exercise   
     Every day 128 32.6
     2-3 times a week   95 24.2
     Occasional 131 33.3
     Never   39   9.9
Smoking   
     <5 a day 112 28.7
     5-20 101 25.4
     >20   4   1.0
     Quit since pregnant  69 17.6
     Quit before pregnant  50 12.6
     I never smoked  61 15.4
Smoking  
     Never smoked  61 15.4
     Quit smoking before or during pregnancy 119 30.1
     Current smoker 216 54.5
Alcohol use  
      Current drinker  44 10.9
      Never drank alcohol  55 13.7
      Quit before or during  pregnancy   303 75.4
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Table 5.4 Behavioural determinants  
           n           % 
Drug use 
    Regular, daily 32   8.2
    Occasionally 40 10.3
    Quit since pregnant 101 25.9
    Quit before pregnant   86 22.1
     I never used such drugs 131 33.6
Drug use  
     Never used drugs 131 33.6
     Quit drug use before or during pregnancy 187 48.0
     Current drug use  72 18.5
Unplanned pregnancy  
     Yes 282 72.1
Vitamin use    
     Yes 
 
265 
 
82.6
 
5.2 Comparison of the Two Sites: HMHB and WC 
Data were collected from two sites, HMHB and WC. Table 5.5 depicts the 
significant differences between the sociodemographic, obstetrical/biological, 
psychological, and behavioural determinants of antenatal depression between the two 
sites. Significantly more of the women from the WC were partnered, Aboriginal, had not 
graduated from Grade 12, and who were either on social assistance or who earned less 
than $20,000 per year.  
There were no significant differences between the obstetrical/biological 
determinants of health between the two groups of women: gestation, somatic health 
complaints, parity, or perceived overall health status. The psychological variables of 
women from both programs were very similar.  However, the “moods up and down” 
variable was significantly increased (p<0.001) in the women at the WC.  
Post hoc analysis showed significant differences between women who exercise 2-
3 times a week and exercise occasionally (p=0.010), and those who exercise 2-3 times a 
week and never exercise (p=0.016). There were significant differences between the 
women who had never smoked and quit smoking (p=0.023) and those who had never 
smoked and currently smoked (p=0.020). There were significant associations between 
women who used currently use drugs and those who had never used drugs (p=0.010) and 
those who had quit using drugs and those who were currently using drugs (p=0.022).  
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Table 5.5 Comparison of significant determinants between the two sites 
 HMHB  (n=330)   WC (n=72)  
                  n         %            n        %     p 
Marital Status  
     Non-partnered 189     59.2 24     42.1 0.012
     Partnered 130     40.8 33      57.9 
Ethnicity  
     Aboriginal  194     59.1 61     98.4 <0.001
     Non-Aboriginal 134     40.9   1       1.6 
Education  
      <Grade 12 189     57.3 58     84.1 <0.001
      >Grade 12 141     42.7 11     15.9 
Moods up and down     
      Yes 132    43.6   53     85.5 <0.001
      No 171    56.4    9     14.5 
Exercise  0.017
      Every day 95    29.5 33    46.5 
      2-3 times a week 84    26.1 11    15.5 
      Occasional 113    35.1 18    25.4 
      Never     30      9.3   9    12.7 
Smoking  0.042
      Never 57    17.5  4     5.6 
      Quit smoking during or  
      before pregnancy 
95    33.8 24   33.8 
      Current smoker 176    53.2 43   60.6 
Drug use  0.019
      Never used such drugs 112    33.9 18     25.0 
      Quit during or before     
      pregnancy 
167    50.6  33    45.8 
      Current drug user  51    15.5   21    29.2 
 
5.3 HMHB Participants Compared to the Non-Participants  
HMHB had entered data into an SPSS file for all women (participants and non-
participants) for the first 6 months of the study. Therefore, limited information was 
available for 83 women who either chose not to participate in the study or who did not 
meet the inclusion criteria.  
Table 5.6 shows that the women who participated in the study were significantly 
more likely to be married and to have completed Grade 12. There was no significant 
difference in either the age or ethnicity of the women or whether or not this was their first 
pregnancy.  
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Table 5.6 Comparison of participants and non-participants of HMHB 
 Participants 
(n=317) 
Non-participants  
(n=83) 
 
                                           n       %          n       %     p 
Marital Status    
    Non-partnered 191    59.1 62    74.2 0.009
    Partnered 132   40.9  21    25.8
Education 
     <Grade 12 193    59.0 59    71.1 0.044
     >Grade 12 134    41.0 24    28.9
 
PART TWO 
5.4 Prevalence and Incidence of Antenatal Depression 
The prevalence of minor antenatal depressive symptoms in this sample of 402 
high-risk women, in the last seven days, was 53.5% (EPDS >10). Major depressive 
symptoms (EPDS >13) were reported by 29.5% of women. The prevalence of depression 
has been weighted for the age of the non-participants. Figure 5.2 depicts the histogram of 
the EPDS score and reports the mean, median, and mode score. 
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Forty-three percent of the women reported a history of depression. These women 
were separated from those with no reported history of depression to determine the 
difference between the depressive symptoms in the two groups, and also to determine the 
number of women who were experiencing depression for the first time during pregnancy 
(incidence). The mean EPDS score for women with no history of depression was 9.18 + 
4.69 which was significantly lower than that of the women with a history of depression, 
11.68 + 4.88 (p<0.0001). From Table 5.7 we can see that the incidence of major 
depressive symptoms in the women who answered the question (n=384) was 21.7%. 
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Table 5.7 Incidence of depressive symptoms and mean EPDS scores in women 
with history of depression versus those with no history of depression 
 No history of 
depression (n=167) 
History of 
depression (n=217) 
 
          n        %         n        %        p 
Minor depression (EPDS >10)         
     yes      96 44.2 112 67.1 p<0.001
     no 121 55.8 55 32.9 
Major depression (EPDS>13)          
     yes 47 21.7 71 42.5 p<0.001
     no 170 78.3 96 57.5 
 
5.5 Sociodemographic, Obstetrical/Biological, Psychological, and Behavioural 
Determinants of Antenatal Depression 
The sociodemographic determinants income, marital status, and education  
(p <0.25) were entered into the logistic regression model. The final model, Table 5.8, 
shows that women who were on social assistance or earned less than $20,000 were almost 
twice as likely to be depressed. Widowed, separated, and divorced women were at 5 times 
the risk for depression, however, this was a small group (n=10), so the marital status 
variable was used as a dichotomized variable (partnered or non-partnered) in future 
analyses. 
 
Table 5.8 Final model of sociodemographic determinants of antenatal depression 
(n=375) 
 Adjusted 
Odds Ratio 
95% Confidence 
Limits  
 
p 
Income <20,000/social assistance  
     Yes 1.97 1.04,    3.74 0.037
Marital Status    
     Single     1.00  
     Common law 1.12 0.69,    1.81 0.645
     Married 0.39 0.14,    1.01 0.071
     Separated/Divorced, Widowed 5.15 1.28,  20.72 0.021
 
All obstetrical/biological variables p<0.25 were entered into the model using 
Forward Stepwise Logistic Regression. This included: number of pregnancies, number of 
somatic complaints, nausea and vomiting, and overall health today. In the final model for 
the biological/obstetrical determinants (Table 5.9), women who complained of nausea 
and vomiting were almost twice as likely to be depressed as those with no complaints of 
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nausea and vomiting. Women who rated their health as fair or poor report twice as much 
depression as those women who reported feeling good, very good, or excellent. 
 
Table 5.9 Final model of obstetrical/biological determinants of antenatal depression 
(n=396) 
 Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
         p 
Nausea and vomiting  
    Yes 1.89 1.17,    3.05  0.010 
Overall health today  
    Good, very good, excellent 1.00  
    Fair, Poor 1.96 1.21,    3.29 0.006 
 
The variables that measure the psychological determinants p < 0.25 were entered 
into the model for logistic regression using a forward stepwise regression. The regression 
was done twice. First, stress, support, mother antenatal or postpartum depression, moods 
up and down, counselling in the past and now, food security, physical abuse, emotional 
abuse, sexual abuse, and history of depression were entered in the model. The number of 
women who reported a history of antenatal depression and a history of postpartum 
depression decreased the overall number of women who could be used in the regression 
analysis to 212. The overall final model (Table 5.10) did not change by taking out the 
history of either antenatal or postpartum depression, but it was more stable with smaller 
confidence intervals. Therefore, these two variables were left out of the model.  
As the final model for the psychological determinants shows, women with high 
levels of stress were 3.2 times more likely to be depressed, women with medium levels of 
support were less likely to be depressed, and women with high support were 0.05 times 
less likely to be depressed. Women with a history of depression and moods up and down 
were more than twice as likely to experience depression.  
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Table 5.10 Final model of psychological determinants of antenatal depression 
(n=315) 
 Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
   p 
Stress  
    Low 
 
1.00
 
 
 
    High 3.23   1.69,  6.17 <0.001
Support   
    No support 1.00  
    Low  0.09  0.008
    Medium 0.08  0.02,    .06 0.008
    High 0.05   0.01,    .40 0.002
History of depression 2.42 1.42,  4.42 0.001
Moods up and down 1.98 1.15,  3.40 0.013
 
There was no interaction between the terms. There was confounding between 
moods up and down and history of depression. To explore this relationship further cross 
tabulation was done, and a significant relationship was found between these two variables 
(p=0.002). The analysis was repeated using the individual stressors (p<0.25). The 
variables with a p value greater than or equal to 0.25 included: stressors-pregnancy, 
partner, money, children, family, where I live, baby’s health, own health, and work, 
support of partner, physical, emotional, and sexual abuse; food security questions, along 
with history of depression, moods up and down, counselling now and in the past.  
The second logistic regression model for these determinants is shown in Table 
5.11. In this model, women with a history of depression were 2.5 times as likely to be 
depressed and those reporting moods up and down almost twice as likely to be depressed. 
Women who were stressed by their partner and their baby’s health were more than twice 
as likely to be depressed. The support of a friend or female relative was protective for 
depression in this sample.  
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Table 5.11 Second final model of psychological determinants of antenatal depression 
(n=306) 
 Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
         p 
History of depression 2.52 1.45,  4.38 0.001
Moods up and down 1.95 1.11,  3.41 0.019
Stressors  
    Partner 2.33 1.26,  4.32 0.007
    Baby’s health 2.58 1.25,  5.32  0.010
Support   
    Friend 0.53 0.29,   0.99 0.047
    Female relative 0.47 0.24,   0.94 0.031
 
To derive a model of behavioural determinants, all variables p<0.25 were entered 
into the analysis: exercise, smoking, alcohol use, drug use, and unplanned pregnancy. 
Table 5.12 shows the final model from the behavioural variables. Women who exercised 
occasionally were a little more than twice as likely to be depressed and those who never 
exercised were depressed 3 times as often than women who exercised daily. Women who 
had quit smoking were 2.8 times more likely to be depressed and those who were 
currently smoking were depressed 2.9 times as much. No interaction or confounding was 
present.  
 
Table 5.12 Final model of behavioural determinants of antenatal depression (n=382) 
 Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
               p 
Exercise  
     Every day 1.00  
     Occasional 2.15 1.21,  3.82 0.009
     Never 3.16 1.34,  6.54 0.007
Smoking  
     Never smoked 1.00  
     Quit during or before  
     pregnancy 
2.76 1.17,  6.48 0.019
     Current smoker 2.98 1.43,  6.69 0.003
 
5.6 Final Model for Determinants of Antenatal Depression  
When analyzing the final logistic regression, rather than using p < 0.25, a higher 
p-value of <0.10 was used due to the large number of variables. As a result, the following 
variables were included in the analysis: Overall health - dichotomized, nausea and 
vomiting, marital status, stressors - three categories, somatic complaints - five categories, 
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support - 4 categories, sexual abuse, history of depression, moods up and down, exercise, 
smoking, alcohol use, drug use, unplanned pregnancy, income-dichotomized, and 
education-dichotomized.  
The final logistic regression model, as depicted in Table 5.13, shows that 
depression in this group of women was related to a combination of psychological and 
behavioural determinants (n=261). Women with a history of depression were more than 
three times more likely and those whose moods go up and down were twice as likely to 
be depressed. Those women who experienced highest levels of stressors were 2.64 times 
more likely to be depressed. Women who currently smoked were 3.19 times more likely 
to be depressed than those who had never smoked. Support was protective for depression.  
 
Table 5.13 Final model for determinants of antenatal depression (n=261) 
 Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
        p 
Moods up and down 2.97 1.59,  5.53 0.001
Smoking  
    Never smoked 1.00  
    Quit smoking 1.87 0.63,  5.52 0.256
    Current smoker 3.19 1.16,  8.71 0.017
History of depression 3.26 1.75,  5.86 <0.001
Stressor  
    Low stressors 1.00  
    Medium stressors 0.87 0.42,  1.81 0.719
    High 2.64 1.26,  5.07 0.010
Total support 0.61 0.42,  0.89 0.011
 
All combinations of interaction were tested: moods and history of depression, 
moods and support, moods and stress, moods and smoking, history of depression and 
support, history of depression and support, history of depression and stress, history of 
depression and smoking, stress and support, stress and smoking, support and smoking. 
There was no interaction between any of the variables. There was confounding between 
moods up and down and history of depression. 
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5.7 Prevalence and Determinants of Antenatal Depression in Different   
Groups of Women 
 
5.7.1 Aboriginal compared to non-Aboriginal women 
The prevalence of depression in the Aboriginal compared to non-Aboriginal 
women is shown in Table 5.14.  
 
Table 5.14 Prevalence of major depression in Aboriginal and non-Aboriginal 
women 
 n EPDS<13 (%) EPDS>13 (%)   p 
Aboriginal 256 67.8 32.2 0.261 
Non-Aboriginal 134 73.3 26.7  
 
Table 5.15 shows the significant sociodemographic, obstetrical/biological, 
psychological, and behavioural determinants of antenatal depression in the Aboriginal 
compared to non-Aboriginal women. Both groups of women were the same average age, 
but there were some significant differences: more of the Aboriginal women had not 
completed Grade 12, lived on social assistance, but reported that their housing were 
adequate. Significantly more of the Aboriginal women had a greater number of 
pregnancies although the ages of the two groups were similar. Aboriginal women 
reported more worries about food security, less supports, and more difficulty with moods 
going up and down (p=0.054), while more of the non-Aboriginal women reported a 
history of depression.  
There was no significant difference in the number of stressors. More of the 
Aboriginal women currently smoked and had smoked in the past than the non-Aboriginal 
women. The use of alcohol was reported by twice as many Aboriginal women, with only 
nine percent reporting not having used alcohol at some time. Aboriginal women reported 
almost three times as much drug use during pregnancy and fewer had quit before the 
study. There were highly significant differences in the risk behaviours such as tobacco, 
alcohol, and drug use between the two groups.  
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Table 5.15 Comparison of significant determinants in Aboriginal women 
and non-Aboriginal women 
 Aboriginal 
(n=256) 
     Non-Aboriginal   
(n=134) 
 
                                                             n        %             n       %     p 
Education  <0.001
     <Grade 12 185     72.5 57    42.2 
     >Grade 12  70     28.5 78    57.8 
Income  <0.001
     <20,000/social assistance 222    87.4 93    68.9 
     >20,000  32    12.6 42    31.1 
Parity  
    Primipara 82    32.2 67    49.6 0.001
    Multipara 173    67.8 68    50.4 
Support  0.018
    None 16      6.4     2      1.5 
    Low 116    46.4 49    36.6 
    Medium  84    33.6 58    33.6 
    High  34    13.6 25    18.7 
Food Security  0.025
    Low 0 0 
    Medium  107    47.8 68    60.7 
    High  117    52.2 44    39.1 
History of depression  0.023
    Yes 98    39.7  69    52.3 
    No 149    60.3 63    47.7 
Smoking  <0.001
    Current smoker 151   59.4 60   45.8 
    Quit smoking   83    32.7 30   22.9 
    Never smoked  20      7.9 41   31.3 
Alcohol use  0.002
    Current drinker  34    13.3 9     6.7 
    Quit drinking  196    76.9 97   71.9 
    Never drank 25      9.8 29   21.5 
Drug use  <0.001
    Current drug user 60    23.5 11     8.1 
    Quit drug use 125    49.0 70   51.9 
    Never used such drugs 70    27.5 54   40.0 
 
Post hoc analysis showed significant differences between women with no support 
and those with two supports (p=0.026), women with no support and those with three 
supports (p=0.027), those with one support and those with two supports (p=0.042), and 
those with two supports and those with three supports (p=0.041). Significant differences 
were seen between the women who had never smoked and those who had quit smoking 
(p<0.001) and those who never smoked and those who were currently smoking 
(p<0.001). The significant differences in alcohol use were between women who never 
  
64 
used alcohol and those who had quit using alcohol (p=0.004), those who never used 
alcohol and those who currently used alcohol (p=0.001), and those who had quit using 
alcohol and those who were currently using alcohol (p=0.004). Women who never used 
drugs and those who had quit using drugs (p<0.001) and the women who had quit using 
drugs and those who were currently using drugs (p=0.002).  
Logistic regression was done on each separate group including those variables that 
were significant (p<0.25) in the bivariate analysis with the EPDS (>13) in all women. The 
determinants were similar. However, history of depression and moods going up and down 
were twice as likely to be associated with depression in Aboriginal compared to four 
times as likely in the non-Aboriginal women. High levels of stressors were significant in 
only the Aboriginal women. See Table 5.16. 
 
Table 5.16 Final models for antenatal depression in Aboriginal and non-Aboriginal 
women 
Aboriginal women (n=182) Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
     p 
History of depression 2.14 1.07,   4.10 <0.001  
Moods up and down 2.43 1.23,   4.72 <0.001  
Stressors 
    Low                                         
 
1.00
 
    High                                          3.13 1.13,   8.93 0.020
Non-Aboriginal women  (n=99)  
History of depression 4.15 1.44,  12.04 0.008
Moods up/down 4.31 1.45,  12.85 0.008
 
5.7.2  Women 21 and under compared to those over 21 
As expected there was a significant difference (p<0.001) between the age of the 
younger women (18.74 years + 1.16) and the older women (26.69 years + 4.37). Women 
21 and under experience more depressive symptoms, as seen in Table 5.17, but the 
difference was not significant.  
 
 
Table 5.17 Prevalence of depression in women 21 and under compared to 
women over 21 
 n EPDS<13 (%) EPDS>13 (%)      p 
Women 21 and under  197 68.3 31.7 0.382
Women over 21 205 72.6 27.4 
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Table 5.18 illustrates the sociodemographic, obstetrical/biological, psychological, 
and behavioural determinants of antenatal depression in women 21 years of age and under 
compared to those 21 and over. The younger women were significantly more likely to 
earn less, be non-partnered, be on social assistance, and to have not completed Grade 12 
than the older women. While there was no difference in the gestation of younger women 
compared to older women, there was a significant difference in the number of somatic 
complaints and health problems, and the number of pregnancies in the older women. 
There was no difference between the gestations of the pregnancy in the younger versus 
the older women. There were no significant differences in the psychological determinants 
between the two groups. There were few differences between the behavioural 
determinants in the young compared to older women; only the number of women who 
had never used or who had quit using drugs during or before pregnancy was significantly 
different. 
 
 
Table 5.18 Comparison of significant determinants in women 21 and under 
and women over 21 
<21(n=197) >21(n=205) 
                                                       n       %  n        %    p 
Marital Status  
     Non-partnered 117   65.0    96    49.0 0.013
     Partnered   63   35.0  100    51.0 
Education  <0.001
     <Grade 12 151   77.0  96   47.3 
     >Grade 12 45   23.0 107   52.7 
Parity  <0.001
     Primipara 114    57.9 43   21.0 
     Multipara   83    42.1   162   79.0 
Somatic/health problems  <0.001
     0 58   29.4 28   13.7 
     1 47   23.9 46  22.4 
     2 42   21.3 41  20.0 
     3 27   13.7 41  20.0 
     4 or more 23   11.7 49  23.9 
Drug use  0.002
      Current drug user 36   18.3 36   17.6 
      Quit during or before     
      pregnancy 
113   57.4 87   42.4 
      Never used such drugs 48   24.4 82   40.0 
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Post hoc analysis of the significant variables showed differences between the 
women with no somatic complaints compared to those with one complaint (p=0.023), 
those with one compared to two complaints (p=0.027), between those with no complaints 
and those with three complaints (p=0.001), those with no complaints compared to those 
with four complaints (p<0.001), those with two compared to those with four complaints 
(p=0.020), and those with one complaint compared to those with four complaints 
(p=0.017). Only the women who never used drugs were significantly more different than 
those women who had quit using drugs (p=0.001).  
The variables that were used in separate logistic regression analyses with EPDS 
(>13) of all women were re-analyzed with the women 21 and under and over 21 (i.e., 
overall health, nausea and vomiting, stress, food security, support, sexual abuse, history 
of depression, moods up and down, exercise, smoking, alcohol, drugs, unplanned 
pregnancy, income-dichotomized, education-dichotomized to completed grade 12 or not). 
Table 5.19 shows that the adjusted Odds Ratio for the variable moods up and down was 
similar for both groups of women. Women over 21 who had reported low amounts of 
support were 5.71 times more likely to be depressed. Those women who had reported 
their health as excellent were 29% less likely to be depressed. 
 
Table 5.19 Final model of determinants of antenatal depression in women 21 and 
under and women over 21 
Women over 21 (n=128) Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
        p 
Moods up/down 3.61  1.22,   10.75  0.021  
Support   
     High 1.00  
     Low 5.71  0.99,   32.71  0.050  
Rate overall health- 
       Excellent 
 
1.00
 
       Very good 0.02 0.00,     0.14  <0.010   
Women 21 and under (n=125)  
Moods up/down 3.79 1.09,   12.55  0.032  
  
5.7.3  Non-partnered women compared to partnered women 
As shown in Table 5.20, the prevalence of major depressive symptoms in non-
partnered women was 32.9% compared to 28.2 for partnered women.  
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Table 5.20 Prevalence of depression in non-partnered and partnered women 
 n EPDS<13 (%) EPDS>13 (%)       p 
Non-partnered 215 67.1 32.9 0.334
Partnered 163 71.8 28.2 
 
As Table 5.21 shows, more of the non-partnered women fell into the lowest 
income level and more were on social assistance, they were significantly younger, and 
were more likely to have not completed Grade 12. Non-partnered women were 
significantly younger than partnered women (21.9 versus 24.1 years, p<0.001). There 
were few significant differences in the behavioural determinants, with the exception of 
increased current and previous smoking in the non-partnered group (88.9% versus 
76.7%). Non-partnered women reported significantly less support than the partnered 
women did. They also reported significantly more stressors and greater concerns about 
their food security. 
 
Table 5.21 Comparison of significant determinants in non-partnered women and 
partnered women 
 Non-partnered 
(n=215) 
Partnered         
(n=163) 
 
                                                                     n        %             n       %    p 
Income  0.002 
    <20,000/social assistance 178    90.4 125    78.3 
    >20,000  19      9.6 34    21.7 
Overall health today  0.021 
     Excellent 14      7.3 13      8.6 
     Very good 46    24.0 50    33.1 
     Good 87    45.3 70    46.4 
     Fair 30    15.6 16    10.6 
     Poor 15      7.8  2      1.3 
Stressors  <0.002 
     None 16     7.5 35    21.5 
     Low 62   29.5 36    22.1 
     Medium 77   36.8 54    33.1 
     High 58   27.2 38    23.3 
Support  0.014 
     None 12     5.8    5      3.1 
     Low 103   49.5 60    37.3 
     Medium 73   35.1 59    36.6 
     High 20     9.6 37    23.0 
Smoking  0.006 
     Current smoker 123   59.4 79    48.5 
     Quit smoking during or  
      before pregnancy 
 61   29.5 46    28.2 
     Never  23   11.1 38    23.3 
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The post hoc analysis showed significant differences in the perception of health 
category between women with excellent health compared to those with poor health 
(p=0.022), those with very good health compared to those with poor health (p=0.007), 
and those with good health compared to those with poor health (p=0.002). Women who 
experienced no stressors compared to those who said they experienced low levels of 
stressors (p<0.001), those who reported no stressors compared to those with medium 
stressors (p=0.001), and those who stated they had no stressors compared to those who 
stated they had high stressors (p<0.001) but no other combination was relevant. There 
were significant differences between women with no support and those with high support 
(p=0.013), and those with low support and those with high support (p<0.001). In addition, 
there were significant differences between the women who had never smoked and those 
who had quit smoking (p=0.017) and those who had never smoked and those who were 
currently smoking (p=0.002). 
As in the previous analyses, the variables from the bivariate analysis, p<0.10, 
were analyzed by logistic regression separately for the non-partnered women and the 
partnered women. As Table 5.22 reflects, non-partnered women who reported moods 
going up and down have 6.65 times the risk of depression. Partnered women were 6.8 
times more likely to be depressed if they had a history of depression. Rating one’s health 
as “excellent” was protective for depression.  
 
Table 5.22 Final model of determinants of antenatal depression in non-partnered 
and partnered women 
 
Non-partnered women (n=136) 
Adjusted 
Odds Ratio 
95% Confidence 
Limits 
 
       p 
Moods up/down 6.65 2.23, 19.75 0.001 
Partnered women (n=106)  
History of depression 6.80 1.73,  26.62 0.006 
Rate health  
    Excellent 1.00  
   Very good 0.01 0.00,   0.23 0.003 
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5.8 The EPDS score 
The internal reliability of the EPDS was determined by the Cronbach’s alpha 
coefficient. While the EPDS was presented as an overall score for depression screening, 
as Table 5.23 shows, the mean scores of each item differed greatly from a high of 1.66 for 
item 3, blame, to a low of 0.27 for self-harm. 
 
 
Table 5.23 Mean score and SD of EPDS items (0-3) 
  Mean + SD
1 I have been able to laugh and see the funny side of things 0.37 + 0.56
2 I have looked forward with enjoyment to things 0.52 + 0.64
3 I have blamed myself unnecessarily when things went wrong 1.66 + 0.84
4 I have been anxious or worried for no good reason 1.54 + 0.80
5 I have felt scared or panicky for no very good reason 1.19 + 0.90
6 Things have been getting on top of me  1.37 + 0.73
7 I have been so unhappy that I have had difficulty sleeping 0.99 + 0.95
8 I have felt sad or miserable 1.25 + 0.74
9 I have been so unhappy that I have been crying 1.01 + 0.75
10 The thought of harming myself has occurred to me 0.27 + 0.58
 TOTAL 10.17 + 4.81
 Cronbach’s alpha coefficient 0.845
 
5.9 Exploring the EPDS 
An exploratory factor analysis, using Varimax rotation, was done to determine if 
there was more than one underlying dimension to the EPDS in this population of women. 
A minimum factor score of 0.40 was used. As Table 5.24 shows, three factors emerge 
when all of the high-risk women were included in the analysis.  
The first factor included the three shaded items in the first column, 3, 4, and 5, 
which might be described as “anxiety” symptoms (blame, feeling anxious, feeling scared 
or panicky). The Cronbach’s alpha coefficient of these three anxiety items was 0.709.  
The second factor included the shaded items in the second column that may be 
labelled “depressive” symptoms. This included items 1, 2, (ability to laugh, looking 
forward with enjoyment). Munro considers a differential of >0.20 the appropriate cut off 
for inclusion of an item that occurs in more than one factor.(198) In this analysis the 
difference in the score of item 8, sad or miserable in the depression or anxiety factor was 
0.137; however, inclusion of this item in the depression factor improved the Cronbach’s 
alpha coefficient from 0.570 to 0.675, therefore it was left in as a factor. The third factor 
involved one item, 10, self-harm thoughts.  
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Table 5.24 Factor analysis of EPDS (n=402) 
 Factors 
Items on EPDS “Anxiety” “Depression” Self-harm
I have been able to laugh and see the funny side 
of things 
0.088 0.722 0.206 
I have looked forward with enjoyment to things 0.069 0.798 0.031 
I have blamed myself unnecessarily when 
things went wrong 
0.752 0.179 0.012 
I have been anxious or worried for no good 
reason 
0.725 0.073 0.198 
I have felt scared or panicky for no very good 
reason 
0.761 0.089 0.241 
Things have been getting on top of me 0.553 0.485 -0.008 
I have been so unhappy that I have difficulty 
sleeping 
0.453 0.446 0.289 
I have felt sad or miserable 0.445 0.582 0.306 
I have been so unhappy that I have been crying 0.343 0.469 0.490 
The thought of harming myself has occurred to 
me 
0.137 0.144 0.900 
Variance % 25.27 20.18 13.67 
Cronbach’s alpha coefficient 0.709 0.678 
 
The anxiety and the depression factors were summed into new variables, labelled 
subscales. The amount of the EPDS score from the anxiety subscale was 4.39 (43% of the 
variance in the total EPDS score), and the depression subscale was 2.14, accounting for 
21% of the variance, and the one self-harm item was 0.27 (2.6% of the variance in the 
EPDS). Then these subscales were compared in the different groups of women using 
T-tests. Because of the small number of some of the responses on the self-harm item, the 
Mann-Whitney U test was used for this analysis.  
5.10 Determinants Associated with Anxiety, Depression and Self-harm 
The final models for the anxiety, depression, and self-harm subscales were 
determined using linear regression with the significant variables (p<0.25) in individual 
bivariate analyses. See Tables 5.25-5.27. 
5.10.1 Anxiety subscale 
Significant variables moods up and down, history of depression, food security, 
age, number of pregnancies, number of somatic complaints, stress of pregnancy, partner, 
baby’s health, baby’s birth, and money were regressed against the anxiety subscale. The 
final model was shown in Table 5.25, it accounted for only 19% of the variance of the 
anxiety subscale. 
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Table 5.25 Final model for determinants of anxiety subscale (n=232) 
 β 
Coefficients 
95% Confidence 
Limits 
 
            p 
History of depression 0.965 0.54,   1.39 <0.001
Moods up and down 0.641 0.21,   1.06 0.003
Number of pregnancies 0.184 0.07,   0.29 0.002
Stressors 0.287 0.17,   0.40 <0.001
 
5.10.2 Depression subscale 
Significant bivariate variables, food security, number of pregnancies, moods up 
and down, support of partner, mother, friend, female relative, other, history of emotional, 
physical and sexual abuse, income, and ethnicity were regressed against the depression 
subscale. The final model in Table 5.26 accounted for 15.8% of the variance in the 
depression subscale. 
 
 
Table 5.26 Final model for determinants of depression subscale (n=229) 
 β 
Coefficients 
95% Confidence 
Limits 
 
           p 
Moods up and down 0.653 0.32,   0.97 <0.001
Stressors 0.278 0.09,   0.46 0.003
Number of pregnancies 0.082 0.01,   0.18 0.025
Support -0.288 -0.47,  -0.10 0.002
 
5.10.3 Self-harm subscale 
History of depression, moods up and down, support of partner, mother, friend, 
female relative, other, history of physical abuse, ethnicity, education, stress of pregnancy, 
partner, money, own health, baby’s health, children, and family were entered into a linear 
regression against the self-harm item. The final model accounted for 23.8% of the 
variance in the self-harm subscale. 
 
Table 5.27 Final model for determinants of self-harm subscale (n=321 ) 
 β 
Coefficients 
95% Confidence 
Limits 
 
     p 
Moods up and down 0.142 0.01,  0.27 0.031 
Stressors 0.089 0.05,  0.12 <0.001 
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The prevalence of self-harm thoughts in the last seven days was examined in all 
women using the self-harm subscale. This included women who were depressed, 
Aboriginal, non-partnered, 21 and under, and those who currently used alcohol.  
As Table 5.28 shows, depressed women were most likely to express thoughts of 
self-harm. The women who reported that they currently used alcohol were most likely to 
state that they had thought of suicide often in the last seven days. Twenty-three percent of 
the women 21 and under had self-harm thoughts, but they were the lowest group to report 
having these thoughts often in the last seven days.  
 
Table 5.28 Comparison of self-harm thoughts in different groups of women 
 Never   
(%) 
Yes 
(%) 
Of those who said yes, 
Hardly ever    Sometimes    Yes, often
(%)                 (%)                (%)
All women (n=402) 79.6 20.4 15.1 4.3 1.0
Depressed women (n=117)  52.1 47.9 30.8 13.7 3.4
Aboriginal women (n=253) 76.5 23.5 16.1 5.9 1.6
Non-partnered women (n=211) 76.0 24.0 18.3 4.7 0.9
Women <21years (n=197) 76.7 23.3 17.0 5.7 0.6
Alcohol users (n=54) 69.0 31.0 20.9 4.7 4.7
 
5.11 Comparison of the EPDS Factors in the Different Groups of Women 
Table 5.29 shows the differences between mean anxiety, depression, and self-
harm scores for Aboriginal and non-Aboriginal women. It appears that there was no 
significant difference between the mean anxiety score in the Aboriginal compared to non-
Aboriginal women; however, there was a significant difference between them in the 
depression items and the self-harm thoughts.  
There was no statistically significant difference between non-partnered and 
partnered women in the either the anxiety or depression subscale or the self-harm item. 
The younger women were significantly more likely to experience anxiety symptoms 
compared to older women. There was no significant difference between the two groups in 
the depression subscale or the thoughts of self-harm item.  
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Table 5.29 Comparison of factors of EPDS in different groups of women 
 Aboriginal 
(n=255) 
Non-
Aboriginal 
(n=134) 
Non-
partnered 
(n=215)  
Partnered 
(n=163) 
Age <21 
(n=125) 
Age >21 
(n=277) 
Anxiety subscale  (range = 0-9)  
Mean + SD 4.43+1.58 4.43+1.37 4.54+2.06 4.32+1.95 4.70+2.04 4.10+1.98
p* 0.77 0.28 <0.01 
       
Cronbach’s 
alpha  
0.678 0.677 0.750 0.642 0.676 0.709
Depression subscale (range = 0-8) 
Mean +SD 2.30 +2.02 1.88+2.05 2.23+1.51 2.08+1.56 2.20+1.52 2.06+1.56
p* <0.01 0.35 0.36 
       
Cronbach’s 
alpha  
0.689 0.737 0.683 0.688 0.682 0.673
Self-harm (range = 0-3)      
Mean +SD 0.33+0.66 0.17+0.41 0.31+0.57 0.23+0.56 0.25+0.57 0.29+0.59
p** 0.006 0.207 0.460 
 *significance p<0.05, determined using independent sample t-test 
** significance p<0.05, determined using Mann-Whitney U-test 
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CHAPTER 6 
DISCUSSION 
This discussion of antenatal depression and its determinants, as outlined in the 
proposed theoretical model, provides a detailed response to the findings of the study in 
relation to the literature. Also, future directions for research are proposed. 
With 402 participants, this study was one of the larger epidemiological studies of 
the six studies of high-risk pregnant women where antenatal depression was the outcome 
of interest (Appendix A).  
6.1 Prevalence and Incidence of Antenatal Depression 
Women in this study showed increased levels of depressive symptoms, with the 
prevalence of antenatal depression of 29.5%. This was similar to the rates (25-29%) 
found in other studies of high-risk pregnant women and in our pilot study (Appendices B 
and C).(5, 12, 67, 68, 70, 82) 
Most of the women in this study were in their second trimester; the average 
gestation was 15.2 + 6.5 weeks. In a study of 128 women in their second trimester, Jesse 
et al. found 27% of the women were depressed.(68) Hobfall et al. found similar rates of 
depression in women in their second and third trimesters (27.6% and 24.5%).(12) Also 
using the EPDS, Bolton et al. reported a depression rate of 29% in 407 inner-city women 
in the UK, 25% in the 2nd trimester and 75% in the 3rd trimester.(67) The high rates of 
depression in the second trimester found in these studies challenge the myth that this is 
the time of least depression in the perinatal period.(48, 51)  
The incidence of depression in pregnancy, that is women who report depression 
for the first time (i.e., no history of depression) during this pregnancy was 21.7%: this 
was half the rate of women with a history of depression (42.5%, p<0.001). While 
previous studies have cited the importance of past psychiatric problems and specifically 
history of depression as precursors for depression,(69, 70) I was unable to find comparable 
incidence rates of depression in pregnancy in the literature. Women who report that they
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have not experienced depression before may not have attributed their feelings as 
depressive. In an evaluation of the Postpartum Depression Support Program in Saskatoon, 
61% of the women had experienced a previous depression and 40% of the women were 
attending the group following their second delivery. Many of the women said that they 
had been depressed in the past but had not realized what was happening to them and that 
their doctors did not diagnose the depression until it became very severe with the second 
child.(206) 
6.2 Determinants of Antenatal Depression 
The women in this study were identified as high-risk by the programs that they 
were recruited through. The analysis of the determinants confirmed that the women in the 
study had lower income, lower level of education, a majority were of Aboriginal status, 
and overall they were younger than the average woman having a baby.   
6.2.1 Sociodemographic determinants 
Approximately 13% of women who deliver in the Saskatoon Health Region are 
Aboriginal.(207) Almost two-thirds of the women in this study self-identified as either 
Aboriginal or Métis. Ethnicity was associated with increased depressive symptoms on the 
both the overall EPDS score but most notably on the depression subscale, which was 
discussed in detail in sections 6.4.1 and 6.7. The mean age of women in the study was 
22.8 years. This was much younger than the average age of other new mothers in 
Saskatchewan, which is 27.6 and in Canada where the average age of women giving birth 
is 29.0 years.(208)  
More than half of the women in this study were non-partnered (never married, 
widowed, separated, or divorced). Lone motherhood has been associated with depression, 
higher levels of stress and increased use of the mental health system.(7, 162) As with 
previous research, women in this study who were separated, divorced or widowed 
experienced significantly more depressive symptoms than married or never married 
women.(69, 209)  
Almost two-thirds of the women in this study had not completed Grade 12. Most 
of the women in the study were Aboriginal. Over half of Canadian Aboriginal adults have 
not completed high-school.(210) There are contradictory reports of the association between 
low education and depression. Most studies have found the likelihood of depression was 
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lower among women who completed high-school,(67, 69, 211) but Hobfall et al., like this 
study, found no association in bivariate comparisons.(12) As many as 85% of the study 
participants lived on less than $20,000 per year or on social assistance, compared to 
26.9% of families with children in Saskatoon who live below the poverty line.(212) 
 6.2.2 Obstetrical and biological determinants 
Women were seen at their first prenatal visit early in the second trimester of 
pregnancy (15.2 + 6.2 weeks). This was later than would be advised for adequate prenatal 
care,(70) however women in the HMHB program might have already visited their family 
doctor prior to joining the program. Women in Saskatchewan, aged 15-49, give birth to 
1.9 children which was higher than the national average of 1.5 children per woman.(208)  
The women in this study had an average of 2.6 + 2.03 pregnancies (including this 
pregnancy), which was close to the average number of births to Aboriginal women (2.7) 
in Saskatchewan.(163) Despite the higher than average number of pregnancies in this group 
of low-income, mostly non-partnered women, increased parity was not associated with 
depression in the final model except in the anxiety and depression subscale. 
Authors of previous studies have attributed a history of abortions as a risk factor 
for depression in the present pregnancy.(19, 58) According to Koyama and Williams,(213) up 
to 40% of women may have had an abortion sometime in their reproductive life. This is 
almost double the 26% of women in this sample who reported having had an abortion. 
There was no association between either having had an abortion or the number of 
previous abortions and depression in this sample; however, intentional, therapeutic 
abortions and miscarriages were not differentiated in this study, so this lack of association 
may not be meaningful.   
As with Kelly et al.,(49) there was a significant bivariate association between 
nausea and vomiting and depressive symptoms, with depressed women more than twice 
as likely to report nausea and vomiting. Pregnant women are reported to underestimate 
their illness during pregnancy(201) and since this information was based on recall and was 
collected early in pregnancy, a stronger association might be found by looking at the 
prenatal record at the end of the pregnancy. 
Rating one’s health as poor has been linked to increased likelihood of depression 
in pregnancy.(56) Similarly, women in this study who reported their overall health as either 
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fair or poor were twice as likely to experience depression as those who rated it as either 
excellent, very good, or good.  
6.2.3 Psychological determinants 
Over forty percent of the women in this study reported a history of depression. 
This was twice the rate seen in a study of Brazilian inner-city women by Lovisi et al..(69) 
They reported an almost 8-fold increase in depression symptoms in women with a history 
of depression(69) and women in a primary care setting were 4.9 times more likely to have 
antenatal depression(56) compared to a 2.67 times increase in the bivariate analysis in this 
study.  
Mood swings were associated with depression, anxiety, and with self-harm 
thoughts. There may be a perceived overlap between mood swings and depression and 
some may believe them to be the same concept, but there was no evidence of collinearity 
between mood swings and depression in this study (Tolerance = 0.984). Other studies 
found that mood swings were independently associated with depression and anxiety.(55) 
Frequent changes in mood are important as they may represent an increased vulnerability 
to developing depression.(184) 
Life stressors have been associated with increased depression in pregnancy,(214) 
and with emotional dysregulation.(11) Women in this study, as with other high-risk 
studies, reported high levels of stressors linked to increased depressive symptoms.(68, 69) 
The most frequently reported source of stressors were money (39.9%), partner (27.5%), 
family (19.8%), and “other” (28.6%). But there were significant bivariate associations 
between depression and stressors related to the partner (p<0.001), money (p=0.030), 
children (p=0.034), family (p=0.002), where the woman lives (p=0.023), the health of the 
baby (p=0.001), and the woman’s own health (p<0.001). Similar to other studies of 
pregnant women, the women in this study reported feeling increased stress about being 
pregnant and particularly about the health of the baby.(215, 216)  
Consistent with previous studies, social support, particularly from the partner was 
significantly associated with a lower likelihood of antenatal depression in bivariate 
analysis and in the final model.(6, 67, 175) However, some studies of inner-city women have 
noted a lack of a significant association between support and depression,(69) which may 
have been due to the tools that they used to assess support. 
  
78 
6.2.4 Behavioural determinants 
Exercise has been reported to elevate mood and decrease the symptoms of major 
depressive disorder.(217) This study shows a clear link between depressive symptoms and 
exercise. There was a dose-response with depressive symptoms between women who get 
20 minutes of exercise daily compared to those women who exercised 2-3 times a week 
(OR 1.72, 95% CI 0.92, 3.20), occasionally exercised (OR 2.23, 95% CI 1.26, 3.92), or 
who never exercised (OR 3.18 95% CI 1.47, 6.87). Only 9.9% of women in the study 
reported never exercising, however according to the staff at WC, 20 minutes of exercise 
each day would not difficult to achieve for most of the women, as they were unlikely to 
have vehicles and therefore, walk to shops or to attend appointments. 
The relationship between current and previous smoking and depression in 
pregnancy has been identified by others.(15, 77) Smoking in pregnancy is linked to preterm 
birth,(91, 103) respiratory and behavioural problems in children,(186, 218) increased alcohol 
use,(187) and drug use.(219) The rate of smoking in this sample was high (55%) compared to 
other pregnant women in Saskatchewan (20%)(220) and to pregnant women in Canada 
(9%).(221) In the pilot study, 75% of the women had reported current tobacco use, and 
HMHB had implemented smoking cessation and second-hand smoking information to the 
mothers in the intervening time.(82) Only 15% of the women in the study reported having 
never smoked compared to 60% in the general population of women aged 20-44 
years.(220) 
This study confirms a dose-response for depression and smoking in pregnancy 
that was previously reported by Zhu et al..(77) Previous smokers were 2.87 times more 
likely (95% CI 1.24, 6.56), and current smokers 3.31 times more likely (95% CI 1.495, 
7.338) to be depressed than women who reported never smoking. While similar 
proportions of primigravidas and multigravidas had either never smoked or quit smoking, 
as with other studies, the multigravidous women were more likely to be current smokers 
(31% versus 69%).(15) 
Alcohol use in pregnancy is problematic due to effects of its use on the 
developing fetus,(188) but also because of the depressant effects of alcohol and the high 
comorbidity of alcohol abuse and depression.(187) Thirty-five percent of the depressed 
pregnant women (14-17 weeks gestation) studied by Pajulo et al. reported using 
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alcohol.(14) Contrary to these findings, just over 10% of women in this study stated that 
they currently used alcohol. This prevalence is in keeping with, or is higher than other 
studies of alcohol use and antenatal depression in high-risk women,(70, 211) but according 
to the Public Health Agency of Canada 13% of women in Canada drink in pregnancy.(222) 
The rate of drinking found in this study may be lower than the national average because 
the women were asked once, early in pregnancy, whether they drank, rather than being 
asked at the end of pregnancy or after the baby was born if they had consumed any 
alcohol during the entire pregnancy. In the pilot study data, the number of women who 
admitted to using alcohol on the discharge interview was 35% compared to 16% who 
acknowledged drinking at the time of their initial interview in pregnancy. As a result, the 
drinking rate reported in this study was likely underestimated.  
The women who had quit drinking before or since becoming pregnant were twice 
as likely to be depressed compared to the women who stated that they had never used 
alcohol in the bivariate analysis. Over 30% of women who had currently or previously 
used alcohol scored >13 on the EPDS compared to 18% of the women who reported 
never using alcohol (OR 2.06, 95% CI 1.00, 4.24). Women may have undereported the 
amount of alcohol that they consumed because the data were collected by HMHB 
program staff who counsel the women to decrease their substance use in pregnancy, 15% 
of the women who attended WC stated that they currently drank alcohol, but this was not 
a significantly increased amount compared to HMHB. Staff at WC suspected that the 
lower than expected rate of drinking in this group did not mean that they were not 
engaged in substance abuse, and that probably there was increased use of illicit drugs by 
the women. 
Indeed, more women in the study did use drugs compared to alcohol. Eighteen 
and a half percent of women in the study stated that they currently used drugs, with 8.2% 
reporting daily use of some illicit substance. One other study of high-risk women reported 
that 14.3% of women used marijuana in the past 30 days and found a significant 
association (p<0.001) with depressive symptoms.(219) A study in downtown Toronto, 
Canada, found that 12.5% of babies born had been exposed to cocaine before birth.(223) 
Women who had quit using drugs either during or before pregnancy were 1.67 (95% CI 
1.00, 2.78) times more likely to be depressed and those who had currently used drugs 
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have 1.85 times the likelihood for depression (95% CI 0.98, 3.50) compared to women 
who had never used drugs. 
The majority of women in the study reported that they use prenatal vitamin 
supplements (82.6%), but unlike other studies there was no association with depressive 
symptoms.(10) This lack of association may be related to the fact that the nurses of the 
HMHB program distribute vitamin supplements to the women and they may not have 
been honest to the nurses about their vitamin use.  
Some studies have found unplanned pregnancy has a significant association with 
depression.(224) This was important as almost three-quarters of the women in the study 
had not planned the present pregnancy, which was higher than the 50% of pregnancies 
that are usually reported as unplanned.(225) In a telephone survey of 300 women in 
Ontario, only 29% of the pregnancies were unplanned.(226) Unplanned pregnancy was 
associated with low education and low income in other high-risk samples of women.(69) 
There was a bivariate association between unplanned pregnancy and depression, but not 
planning the pregnancy was not significant in the final model. 
Figure 6.1 summarizes the determinants of antenatal depression in this sample. 
The determinants of antenatal depression that were proposed as being in the study but 
were not significantly associated are in plain font. The determinants that were found to be 
significant in the bivariate analysis and each determinant are in italics. Finally, those 
determinants that were significant in the final model are presented in bolded font.  
It appears from the final regression model that depression, in this sample of high-
risk pregnant women, was related more to psychological determinants than to the other 
determinants analyzed in this study. Previous history of depression, mood swings, 
stressful events, and level of support all had strong and significant associations for 
depressive symptoms. The only behavioural determinant in the final model was current 
smoking status.  
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Figure 6.1 Determinants of antenatal depression  
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6.3 Antenatal Depression in Aboriginal, Younger and Non-Partnered Women  
The prevalence and determinants of depression were compared between the 
Aboriginal and non-Aboriginal, the women 21 years of age and under and those over 21, 
and non-partnered and partnered women. 
6.3.1 Aboriginal women 
The Aboriginal women in this study experienced significantly lower income 
(87.4% versus 68.9%), lower levels of education (72.5% versus 42.2%), and less of them 
experienced high levels of support (41.7% versus 69.2%) than the non-Aboriginal women 
did. Aboriginal women also had significantly more current or previous substance use: 
smoking (98.1% versus 68.7%), alcohol (91.2% versus 78.5%), and drugs (72.5% versus 
60%). Aboriginal women had significantly higher levels of depressive symptoms and 
self-harm thoughts as measured by the subscales of the EPDS, but not on the overall 
EPDS score.  
Other research has identified lack of significant difference in the prevalence of 
depression among women in ethnic minorities.(12, 67, 154) It may be that although the EPDS 
has been tested in multiple cultures, languages, dialects, and settings in prenatal and 
postnatal women throughout the world, including a group of urban Aboriginal women in 
Saskatchewan, that it does not detect depression as precisely in this group of women. The 
women may express their despair in different ways from other women. It might also mean 
that despite all the challenges and inequities that would be expected to put them at 
increased risk for depression, these women were resilient and tended not to get as 
depressed. Regardless of their life circumstances, it is interesting to note that only 39.7% 
of Aboriginal women stated that they had a history of depression compared to 52.3% of 
the non-Aboriginal women, but when they did have a history of depression, it was 
significantly associated with antenatal depression.  
6.3.2 Women under 21  
It was expected that women 21 and under would be at greater risk for depression 
as they would have other risk factors potentially associated with depression (e.g., non-
partnered, lower income). Women under 21 were more likely to be non-partnered (65.0% 
versus 49.0%), to not have completed Grade 12 (77.0% versus 47.3%), to be in their first 
pregnancy (57.9% versus 21.0%), and they were significantly more likely to have used 
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drugs (75.6% versus 60.0%). Women 21 and under did experience more depression: more 
of the younger women scored higher on the EPDS, but the difference was not statistically 
significant. Having their moods go up and down was significant for depression in both 
groups of women, but having low levels of support and self-rated health described as poor 
were significantly associated with depression in the final model of the women over 21. 
6.3.3 Non-partnered women 
It was expected that the non-partnered women would be more likely to be 
depressed because of their potentially lower income, younger age, and lack of support. 
The non-partnered women in this study were significantly more likely to be younger, be 
on social assistance, rate their overall health as poor, and reported less supports and more 
stressors. Research has shown that pregnant women’s smoking habits echo that of their 
peers and partners and that they are more likely to quit if their partner also quits and 
supports their abstinence, so it could be expected that non-partnered women would smoke 
more as they lack the support to quit.(219) Indeed, more non-partnered women in this study 
smoked than partnered women (59.4% versus 48.5%).  
One might expect that given the prospect of lone parenthood, the non-partnered 
women in this study would experience more depressive symptoms than the partnered 
women, but the difference was not significant. This is in contrast to other studies.(12, 67, 69) 
But as with other research, the rate of depression was highest in the separated/ 
divorced/widowed group (OR 1.72, 95% CI 1.31, 2.23),(69) but very few women in this 
study fell into this category: most were either never married or in a partnered relationship 
(married or common-law). It may be that these non-partnered women, who were mostly 
on social assistance, were reluctant to report their relationship status due to fear of being 
penalized by social services through discontinuation or lessening of their funding.  
6.4 Factors of the EPDS 
Consistent with other studies, this study confirmed that the EPDS measures not 
one but different factors of depressive mood such as anxiety.(155-157, 227) Adouard et al.(227) 
found two factors somewhat similar to those in this study in 60 women in obstetrically 
high-risk pregnant woman, with the ‘anxiety’ factor accounting for the greater amount of 
the variance in the total score. Self-harm thoughts were included in this first factor. The 
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researchers used a principal component rather than an exploratory factor analysis, which 
may have limited expression of further factors.  
While the anxiety subscale was the prominent feature in this sample of pregnant 
women, it was the depressive symptom subscale, which explained most of the variance in 
150 postpartum Canadian women (27.0% postpartum versus 20.1% in the pregnant 
women).(156) Both studies had reported the factor composition and variance of the anxiety 
factor similar to this study (25.2% versus 25.4%). The third factor, self-harm thoughts, 
explained similar magnitude of variance in both studies: 13.6% in the pregnant women 
and 14.7% in the postpartum women.(156)   
As with studies of the general population,(228) there were significantly more 
anxiety symptoms in the younger women. There was no significant difference between 
anxiety symptoms between either the Aboriginal and non-Aboriginal women or the non-
partnered and partnered women. Other researchers have found a history of depression was 
strongly associated with anxiety in pregnancy, (229) and women in this study were more 
than four times as likely to have anxiety symptoms compared to women without a history 
of depression. 
6.4.1 Self-harm thoughts 
Suicide in pregnancy may be rare,(57, 81) but as this study confirms, self-harm 
thoughts were not uncommon in this group of pregnant women. According to Statistics 
Canada, 3.8% of all women will have had suicidal thoughts in the last year, with the 
highest rate of all age categories, in both genders, in the women in the 15-24 year age 
group (7.3%).(230) However, 20% of women in this study had self-harm thoughts in the 
past seven days. The highest level was in the women with symptoms of major depression, 
followed by those women currently using alcohol. This comorbidity of increased suicidal 
thoughts and alcohol use was also affirmed by Homish et al.(187) While there was the 
expected increase in the self-harm thoughts in the younger women in this sample 
(23.3%), this was not a significant increase, and only 0.6% stated that they had thought of 
self-harm often in the last seven days. 
6.5 Implications for Future Research 
Currently, building on the research in this thesis, research is underway on 
antenatal and postnatal depression on a larger sample of 650 women from the general 
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population in Saskatoon, Canada. As a result, we were able to train and hire interviewers 
whose only role is to collect the data. We have included all of the questions from this 
original study, but also added other items and questionnaires based on preliminary data 
analysis from this study.  
For example, to more fully understand the sources of anxiety and stressors, we 
have included the Cambridge Worry Scale,(231) which measures specific worries in early 
and late pregnancy as well as in the postpartum. Because of the significant association of 
nausea and vomiting with depression in this study and others,(49) we have added a tool 
that more accurately measures nausea and retching, as well as the amount of vomiting in 
pregnancy.(232) Measures were also added about the impact of neighbourhood 
characteristics on antenatal depression.  
Having moods that go up and down was significantly associated with depression 
in this study. Therefore, we have included more questions about mood and a visual 
analogue scale of moods at that time, and we have started a small substudy to explore 
mood changes in pregnancy in greater detail. Women will record their mood symptoms 
twice a day for one week on three occasions. We will be able to compare the data to 
studies in non-pregnant women with and without premenstrual syndrome (PMS), and to 
women with alcohol problems. 
Alcohol use was an important comorbid factor in depression severity and suicide 
thoughts, but it is also harmful to the fetus.(188) We have incorporated additional and more 
specific questions about alcohol use taken from the Canadian Community Health 
Survey(233) and the TWEAK.(203) We also included two questions adapted from the 
PRIME-MD “Over the past two weeks, have you ever felt down, depressed, or hopeless?” 
and (2) “Have you felt little interest or pleasure in doing things?” that have been validated 
to establish depressive status in obstetric, gynaecologic, and other populations.(234, 235) 
While this and the ongoing longitudinal study will provide ample quantitative data 
to describe the prevalence and determinants of antenatal depression, it is also important to 
understand women’s lived experiences with antenatal depression. We have funded a 
graduate student to conduct a qualitative study of women experiencing their first 
depression in their present pregnancy.  
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While the EPDS has been extensively validated worldwide in many cultures, 
languages, and in community samples of pregnant women, it was not validated in this 
sample. An attempt was made early on to engage a psychiatric resident in the project but 
this was not feasible at this time.  
6.6 Lessons Learned 
I have been asked how I chose a thesis topic that would be of such interest and 
significance. This was not intentional. While completing two CUISR (Community-
University Institutes for Social Research) projects, one an evaluation of the Postpartum 
Depression Group(146, 206) and the other an evaluation assessment of the HMHB 
program,(146, 206) I noticed that women seeking help from postpartum depression were 
more likely to be married, well-educated, and Caucasian than the women participating in 
the HMHB. I recognized that given the inequities in the sociodemographic status of these 
different groups of women, surely the women at HMHB would be at high-risk for 
depression. Once I reviewed the literature and realized that antenatal depression was a 
significant problem with the potential to have a profound effect on the health of pregnant 
women and their babies, I became passionate about conducting this study.  
Starting a new facet of my career after 30 years in nursing has been exciting, but 
research was also an arduous process. I have learned to be patient with tasks outside my 
immediate control, such as ethics approval and data collection. I have also been involved 
in preparation, submission, and success with grants on the local and on a national level. I 
have successfully endured the rigors of publishing two articles from the development of 
this project in refereed journals and have another submitted.  
6.7 Summary 
This study confirms the high prevalence of depression and self-harm thoughts in a 
high-risk group of 402 pregnant women in Saskatoon, Canada. It has identified a model 
of determinants for antenatal depression that were unique to the women this study: history 
of depression, moods up and down, stressors, cigarette smoking, and unplanned 
pregnancy. The study also confirms the existence of multiple factors within the EPDS 
including a predominance of anxiety rather than depression symptoms in pregnancy 
compared to postpartum women, and significantly increased anxiety in the younger 
women. 
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CHAPTER 7 
 
CONCLUSIONS: IMPLICATIONS FOR PRACTICE, POLICY, AND 
KNOWLEDGE TRANSLATION ACTIVITIES 
 
According to the World Health Organization, the prevalence of depression is 
increasing and is exacting a huge public health burden on society.(2) Along with the 
physical and psychological changes associated with pregnancy, high-risk women face 
daily challenges with financial hardships, family violence, lone parenthood, greater 
numbers of children, and low education compared to women in the general population. 
Their circumstances must be framed, studied, and be met with policy interventions for 
relief at a primary, secondary, and tertiary prevention as well as a population approach to 
improve their health and the health of their growing families. This includes improving the 
socioeconomic status of women, providing social support, increasing our understanding 
of the unique factors that contribute to depressive symptoms in women, and testing 
interventions that are effective to relieve the misery they experience and the effects on the 
whole family.  
This study confirmed that almost 30% of these high-risk women are experiencing 
high levels of depressive symptoms. As well, there are implications for practice, theory, 
policy, and knowledge translation. 
7.1 Implications for Practice 
Childbirth is a time of increased contact with health services. This provides a 
unique opportunity for the early detection of maternal depression. Screening and 
increased awareness of antenatal and early postpartum depression and its associated risk 
factors will be of interest to primary prevention and outreach programs that focus on the 
care of pregnant women, particularly high-risk women, and their families. By providing 
information about the significant associated determinants in this sample of women (i.e., 
history of depression, moods going up and down, current smoking status, low support, 
and high levels of stressors), caregivers will be better able to recognize women at risk for
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depression in pregnancy and in the early postpartum. Identification and early treatment of 
depression may help to decrease engagement in related risk behaviours and lifestyle 
choices such as smoking, alcohol, and drug use that negatively affect themselves, their 
pregnancies, and their children. 
The project has increased awareness of antenatal and postnatal depression in 
Saskatoon. As a result of the study, local physicians who are now identifying depression 
in their pregnant clients requested access to specialized care. Therefore, in association 
with a psychiatrist who specializes in mood and anxiety disorders, Dr. Marilyn Baetz, we 
have initiated a Maternal Mental Health Program for pregnant and postpartum women 
suffering from mental illness, particularly depression, within a primary care centre in the 
Saskatoon Health Region. In addition, we were recently successful in getting funding 
from the Royal University Hospital Foundation in Saskatoon to conduct and evaluate the 
effectiveness of an Antenatal Depression Intervention Group.  
7.2 Implications for Policy 
Sobey blames the absence of public policy, the discrepancy between insurers for 
mental health coverage, and the lack of screening as the major reasons for lack of 
movement on strategies to prevent postpartum depression in the United States.(45) 
Screening is an effective strategy for reducing morbidity in depressed people(236) and 
screening women for depression in pregnancy and during the postpartum is used in 
increasing frequency in the United Kingdom and Australia.(153, 159) In Canada, British 
Columbia recently presented guidelines for perinatal depression screening and care.(237) 
Calgary has been evaluating all women at 6-weeks postpartum for depression using the 
EPDS. And in Ontario, the Best Start Program began a campaign to screen women for 
postpartum depression in March 2007.(238) These campaigns will promote primary and 
secondary levels of intervention for awareness antenatal depression. 
There is presently no routine screening for antenatal depression in Saskatchewan, 
and women may not get help until they are very ill. For instance, over 60% of the women 
who sought help from the Postpartum Depression Support Program in Saskatoon had 
thoughts of harming themselves or their baby prior to calling for help.(206) Without a 
systematic method to detect for antenatal depression, women and their families will 
continue to suffer unnecessarily. Universal screening for depression in pregnant women 
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with the EPDS is a procedure that would take caregivers in Saskatchewan approximately 
five minutes to complete.  
I have tried to get the EPDS included in the routine prenatal assessments by 
having it included in the provincial prenatal forms completed by all physicians and nurse 
practitioners in the province for each pregnant woman. The latest revision of the prenatal 
form is in progress but the group would only provide space for two questions. The two 
questions from the PRIME-MD scale (Over the past two weeks, have you ever felt down, 
depressed, or hopeless? and Have you felt little interest or pleasure in doing things?) were 
submitted for inclusion.(235)  
7.3 Implications for Theory 
Increased awareness of the frequency and effects of antenatal depression 
symptoms will promote primary prevention in women and the sequelae in their unborn 
children. Screening, early identification, and treatments during routine prenatal visits will 
increase secondary prevention. It may also help to decrease the stigma, shame, and guilt 
that often prevent women from seeking help for mental health problems in pregnancy. 
Screening women with the EPDS can quickly identify women with self-harm thoughts 
and potentially avert a tragedy.  
The determinants of antenatal depression in this study point to psychological 
health (history of depression, moods going up and down, and high levels of stress). This 
speaks to a need for both primary and secondary prevention strategies to alleviate 
depressive symptoms in the mother. Identifying women with a history of psychiatric 
problems and stressors early can potentially prevent depression from developing or 
worsening in those who are vulnerable. Providing support with tobacco cessation may 
help women avert some depressions. Secondary intervention such as universal depression 
screening can decrease morbidity for the mother now,(236) promote primary prevention of 
postpartum depression(62, 66) and primary prevention of the effects of depression on the 
fetus.  
7.4 Knowledge Translation Activities 
Increasing awareness about the prevalence and understanding the determinants of 
depression in this high-risk population of pregnant women will help to inform 
administrators and caregivers within the Saskatoon Health Region of the extent of 
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depression in this group of women and the determinants that may prevent future 
depressions. They will be more able to develop public health policy and implement 
programs that are tailored to this group of women.  
The participatory approach of this study design has included staff, management, 
and clients of both programs. The result is a screening process that they can use on an 
ongoing basis to identify individual women with depression and to monitor their risk 
factors and outcomes and referral to caregivers (Appendix B). It has included education 
about antenatal and postpartum depression to caregivers, administrators, community 
partners of the participating programs, the public, and most importantly to the women 
themselves (Appendix D).  
The evaluation projects done for the Community-University Institutes for Social 
Research (CUISR) of the Postpartum Depression Group and the HMHB program are 
published online.(146, 206) The pilot study of this project was also a CUISR project. It was 
published in a refereed journal.(82) A poster of this thesis won Gold Poster Prize at the 
Canadian Institutes for Health Research, National Poster Competition at the Canadian 
Student Health Research Forum in Winnipeg in June 2007. 
The knowledge translation activities for this project included information about 
antenatal depression in all women, not just those high-risk. This involved numerous oral 
and poster presentations at the local, national, and international level. An online learning 
resource for physicians was produced for Continuing Professional Learning at the College 
of Medicine at the University of Saskatchewan.(239) 
7.5 Final Conclusions 
As this study confirms, depression is a major public and mental health problem. 
Women in this high-risk sample were experiencing depressive symptoms and self-harm 
thoughts at an alarming rate. Younger women experienced higher levels of anxiety, which 
may lead to depression, including postpartum depression. The women with depression in 
this study were more likely to have had a history of psychological, mental health 
problems, and risk behaviours that put them at further risk for depression during 
pregnancy. The women have more pregnancies and their life circumstances were subject 
to more social inequality than other Saskatchewan women. This combination of factors 
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can only lead to ongoing mental and physical health problems for the women, their 
babies, and their families.  
Using a population health approach to study antenatal depression can help to 
identify the unique sociodemographic, obstetrical/biological, psychological, and 
behavioural determinants of health that put women at further risk. This knowledge can 
help us to target interventions that will promote the early identification of women with 
mental health and stress problems before they start to have children. We need to educate 
people about the factors associated with depression, the signs and symptoms, and 
encourage them to seek help for women at risk or suffering from depression.  
Because of the increased risk reported in this study, it is important to assist 
women with tobacco cessation before they become pregnant, to encourage young women 
not to take up smoking, and also to help them to avoid unplanned pregnancies. These 
primary prevention interventions will decrease the possibility of antenatal depression in 
vulnerable women and thereby reduce the exposure to the effects of depression in the 
developing fetus in the womb and decrease the chances of further depression and the 
sequelae in women.   
 Ultimately, the primary prevention of antenatal depression and its affects on the 
mother and the fetus will be successfully accomplished through increased understanding 
of the problem through research studies such as this one. This study will need to be 
followed by multiple levels of knowledge dissemination to further increase the attention 
of the public, professionals, and legislators to the levels of prevention outlined here. 
Policy and programming will need to ensure that early intervention is provided to 
improve the outcome of women’s mental health in pregnancy and the postpartum and the 
lives of their children, in this and future generations.  
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Appendix A. Summary of studies of depression in socially high-risk women  
Author Year Site Sample 
size 
Gestation 
(weeks) 
Tool* Cut
-off  
% 
depressed 
Psycho-
metrics 
Sample 
characteristics 
Determinants of 
depression 
Comments 
Bolton 
et al. 
(67) 
1998 London 
UK 
407  
 
24% -2nd 
trimester 
75.6% -3rd 
trimester 
EPDS 13 29  Age 29+5.47 
33% primip 
28.6% previous 
abortion 
53.5% < Grade 
12 
RR with EPDS >15: 
Supportive partner:2.31 
Single status: 2.43 
Unemployed:2.35 
Multiparous: 2.62 
< Grade 12: 3.40 
States good 
estimate of 
prevalence of 
depression- 
high- risk 
women.  
Bowen  
& 
Muhaja
rine(82) 
2006 Saskato
on 
Canada 
39 15.5 EPDS >13 27  Age 23.2+4.1 
44% primip, 66% 
single, 64% 
Aboriginal, 51% < 
Grade 12 
75% current  
smoker 
Higher mean EPDS in 
women who were 
Aboriginal, single, smokers, 
alcohol users, >21, no 
social support*       
*(p<0.01) 
Small sample 
size 
Da-
Silva et 
al.(6) 
1998 Brazil 33- 
assesse
d in 
home 
during 
pregnan
cy-only 
29 
finished 
antenata
l assess. 
’3rd 
trimester’ 
EPDS >13 37.9 Compared 
Clinical 
assessment   
Sensitivity-
73% 
Specificity-
90.5% in all 
participants 
(ante and 
post natal) 
All low income, 
“100-500US$ a 
month” all other 
data reported as 
depressed versus 
non depressed 
Bivariate associations 
Partner support -p<0.05; 
ethnic origin (Black) p<0.05 
Portuguese 
validation 
study. Very 
small sample 
size. 
Antenatal 
depression 
was not 
associated 
with 
postpartum 
depression 
Hobfall 
et al.   
1995 Ohio, 
US 
232 2nd and 3rd 
trimester 
SADS, 
adapted 
for use 
ante & 
postnatal
-RDC , 
BDI short 
interview 
 27.6 2nd 
trimester 
 
24.5 3rd 
trimester 
 
41.5% 
depressed 
on either  
assessmen
t 
Removed 
pregnancy 
related 
physical 
symptoms. 
SADS 
validated by 
interviews 
using BDI-II 
with 30 
women 2-3 
weeks post 
screen. 
Age 24.5+5.1 
24% < Grade 12 
32.2% employed 
87.6% low 
income 
41.7% were 
single or un-
partnered 
27% African 
American 
Only single, non 
cohabitating status 
associated with depression, 
no association with income, 
education, ethnicity, or 
employment 
 
Jesse 
et al. 
2005 Mid-
western 
US 
130, but 
only 128 
complet
ed the 
depressi
on 
16-28 
weeks 
BDI II 18 27%, mean 
BDI-II 
13.6+9.9 
Did not 
adjust for 
somatic 
symptoms 
associated 
with 
62% African 
American 
58% partnered 
33% < Grade 12 
78% Medicaid 
insurance 
More Caucasian women 
depressed. 
ORs: 
high religiosity 1.3 (p<0.05) 
high stress 1.2 (p<0.01) 
self-esteem 0.8 (p<0.01) 
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Appendix A. Summary of studies of depression in socially high-risk women  
Author Year Site Sample 
size 
Gestation 
(weeks) 
Tool* Cut
-off  
% 
depressed 
Psycho-
metrics 
Sample 
characteristics 
Determinants of 
depression 
Comments 
screen pregnancy  39% currently 
smoked 
28% substance 
use (unspecified) 
adolescents significantly 
higher mean BDI-II scores 
(18.5 versus 12.25) 
Kim et 
al.(70) 
2006 Minneap
olis US 
154, 
however 
127 
complet
ed the 
psychiatr
ic and 
substanc
e abuse 
tools. 
28+7 
weeks 
PRIME-
MD-PHQ 
MDQ 
 25% 
depression 
10% 
anxiety 
31% 
psychiatric 
/substance 
abuse 
disorder 
Did not 
adjust for 
somatic 
symptoms 
in 
pregnancy 
Age 25+5.7 
38% unmarried 
67% social 
assistance, 80% 
ethnic minority 
(32% African 
American, 31% 
Hispanic, 7% 
Native American  
3% alcohol abuse 
Past psychiatric 
history/substance abuse 
and poor prenatal care (OR 
2.76, 95% CI 1.22, 6.22)  
Primary 
outcome: 
prenatal care 
utilization 
Only 61% of 
154 signed 
consent. 
Lovisi 
et al.(69) 
2005 Brazil 230 37.7 weeks CIDI   19.1% 
 
CIDI based 
on ICD-10 
criteria, high 
inter-rater 
reliability 
Diagnosed 
major 
depression, 
single, or 
recurrent in 
past 12 
months 
Age 27.6+5.8 
25% single, 
54.8% non white, 
55.7% low 
education 
24.8% history of 
depression 
Divorced or widowed (OR 
4.9, 95% CI 1.3, 18.3) 
history of depression (OR 
7.9, 95% CI 3.1, 20.5) 
loss of intimate relationship 
(OR 8.4, 95% CI 3.3, 21.4) 
financial difficulties (OR 6.6, 
95% CI 2.5, 17.2) 
family violence (OR 4.2, 
95% CI 1.5, 11.8). 
secondary school education 
was protective (OR 0.5, 
95% CI 0.2, 0.9). Women 
reported lack of emotional & 
social support but no link to 
depression 
 
Orr et 
al.(103) 
2002 
publis
hed 
(study 
-1992-
3) 
Baltimor
e US 
1,399 Recruited 
first 
prenatal 
visit 
CES-D 16  
 
 Prospective 
study 
81% >20; 75% 
>Gr. 12; 78% 
single; 25% 
current smoker; 
7% current 
alcohol use; 9% 
current drug use; 
 Main 
outcome was 
spontaneous 
preterm 
delivery, 
depression 
(OR 1.96, 
95% CI 1.04, 
3.72) for 
preterm 
delivery. No 
evidence of 
dose 
response of 
depression. 
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Appendix A. Summary of studies of depression in socially high-risk women  
Author Year Site Sample 
size 
Gestation 
(weeks) 
Tool* Cut
-off  
% 
depressed 
Psycho-
metrics 
Sample 
characteristics 
Determinants of 
depression 
Comments 
Orr et 
al.(211) 
2006 North 
Carolina
, US 
1163 First 
prenatal 
visit 
CES-D 16  
___ 
23 
49.1% 
Black 
33.5% 
White 
27.% Black 
16.2% 
White 
 Age 78%>20 
70.6% <Grade 12 
56% single 
Black women 
more likely to not 
finish Gr. 12 or 
married 
Black ethnicity(OR 1.54, 
95% CI 1.16, 2.05); < Gr. 12 
(OR 1.62, 95% CI 1.22, 
2.15); single (OR 1.72, 95% 
CI 1.31, 2.23) 
Study was to 
compare 
differences 
between 
black and 
white women 
Vander
Weg(219)  
2004 Memphi
s, TN 
245 Not 
reported 
CES-D 16 % not 
reported. 
Mean  
CES-D 
21.5+11.2 
States tool 
valid in 
pregnancy. 
Did not 
state if 
adjusted for 
somatic 
symptoms 
of 
pregnancy 
Age 25.6+5.2 
41.6% African 
American, 54.3% 
low income, 31% 
employed, 60% < 
Grade 12, 65.5% 
single, 78% 
current smokers, 
14.3% current 
marijuana use 
Multivariate correlates 
(n=239) Self efficacy (partial 
regression coefficient -.88, 
p<0.001; marijuana use 7.1, 
p<0.001; self efficacy for 
quitting smoking 1.2 
p=0.024; self efficacy for 
quitting when depressed-
3.5, p=0.032; nicotine 
dependence .631, p=0.035 
Primary 
outcome: 
smoking in 
low income 
pregnant 
women 
 
*CIDI- Composite International Diagnostic Interview; SADS-Schedule for Affective Disorders and Schizophrenia; RDC-Research Diagnostic Criteria for 
minor and major depression- Gold Standard; BDI-II – Beck Depression Inventory II; PRIME-MD-Primary Care Evaluation of Mental Disorders; MDQ-
Mood Disorders Questionnaire
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Appendix B 
Antenatal, Early Postpartum Depression 
Screening--EPDS. Healthy Mother Healthy Baby
Item 10 + response
Score >13 Score 10 -12
•Emergency
•Crisis intervention
•Self-harm contract
•Intervention
Discuss concerns
Follow-up
Discuss concerns-
further assessmentDiscuss concerns
Recommend Immediate Referral to:
-Family Physician -medication, support
-Postpartum Depression Support Program 
Hotline
-Mental Health Services will see up to 3 
times then on wait list 
-Family support Center
-Teen support Centre -teen parent program
-KidsFirst for those in targeted areas
-Food for Thought, limited intake to 
program of 150/yr
-Community Clinic ~40 clients/yr
Increase visits/contacts
Draft September2004
Offer Referral to :
-Family Physician 
-Postpartum Depression Support 
Program Hotline
-Mental Health Services -wait list
-Family support Center
-Teen support Centre
-KidsFirst
-Food for Thought
-Community Clinic
Increase phone contacts/visits
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Appendix C 
 
Healthy Mother Healthy Baby Program 
9th Floor, Sturdy Stone Centre, Saskatoon, SK S7K 2H6 
306-655-4806 
 
 
 
 
 
 
 
Date:________________________ 
 
 
 
Dear Dr:_______________________________ 
 
 
__________________ is a client of the Healthy Mother Healthy Baby program. We are 
presently involved in a research study that involves screening women for potential 
depression. The score on the depression screen indicates that _______________ may be 
at risk for depression. We are referring her to you for further assessment.  
 
Thank you,  
 
 
 
 
 
_______________________________RN 
Maternal Child Nurse 
Healthy Mother Healthy Baby  
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Appendix E Initial Antenatal and Early Postpartum Depression Screening Study   
 Protocol-changes were communicated in the staff communication book. 
 
Include: 
1. All women who understand English (include teens); you can explain items to women but try 
not to guide their responses. 
2. Women who intend to keep their baby. 
3. Only women less than 20 weeks can be included to start in the study. Although this does not 
prevent you from screening any woman you are concerned about, but they will not be part of 
the study. 
4. The data on women who miscarry, still birth etc will be used as is (e.g., just Time 1 or Time 
2) but they should NOT be given the study questions following the loss. 
5. Women who withdraw from the study will not have their data included in the study. 
6. All women must sign the consent before entering the study; please leave a copy of the consent 
with the woman.  
 
Data collection: 
1. Please ensure that the study #___ and site (HMHB, WC, etc.) is on each sheet. Check all that 
apply if the client belongs to more than one e.g., HMHB and WC. 
2. Please try to get as many items filled completed as possible. 
3. The EPDS (Feelings in Pregnancy and Motherhood) and Lifestyles Questionnaire need to be 
completed at the same visit. 
a. Please always have the woman complete the EPDS first and in private.  
b. While you are scoring the EPDS, please give her the Lifestyles questionnaire to 
complete. You can then discuss the score and potential course of action.  
4. Please try to have everyone who enters the study complete all 3 Times of the study. 
5. Please use all of the appropriate tools at each Time: 1, 2, or 3. 
6. Please try to complete data collection early in the week, in case any follow-up is required. 
7. The original EPDS and Lifestyles questionnaire remains with the chart; the score sheet is 
returned to the manager and then to the researcher. 
 
Time 1. Less than 20 weeks: 
Tools—Yellow 
• Consent 
• Intake Assessment 
• If possible do the EPDS, Lifestyle questionnaire, and Score Sheet, if not can do at next visit 
• Pink brochure “Feelings in Pregnancy and Motherhood” can be given out at any time 
 
Time 2. Greater than 20 weeks and prior to delivery and more than 10 weeks since Time 1.  
(i.e., if Time 1 is done at 17 weeks try not to repeat it until 28 weeks)  
Tools--Lavender 
• EPDS, Lifestyle questionnaire, score sheet 
 
Time 3. In the first three weeks after delivery 
Tools--light green 
• EPDS, score sheet, lifestyle questionnaire  
• Discharge database 
 
If there are any questions, they or you can call 966-7930 - Angela or Dr. Muhajarine. 
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NAME__________________________________________________________________ 
                              Surname                                      First                                                                                     
Do you use any other name?_________________________________________________   
Address: __________________________________________Postal Code:______  ____ 
Phone Number  ________________  Cell Number  ___________________   1No Phone 
Alternate Contact:__________________________________Phone#____________________ 
 
HOUSING   1 own    1 rent    1 parents    1 room & board    1 YWCA    1 other 
# of adults in household_____     # of children under 18______ 
 
Adequate/suitable   1yes  1no  1unknown      Plan to move:  1yes  1no   when?____ 
 
Do you have any financial concerns:   ?Yes   ?No    
Are you getting?   ?DCRE  ?Employment Supplement   ?Band funding  ? Student loan    ?PTA     
?parents    ?partner            ?___________________ _______________ 
 
Do you work?  ?Yes   ?No         ?Work where?                                                                
 
In the past 12 months, did you or anyone else in your house.   
     Not have enough food to eat?  ?Yes   ?No    
     Worry that there would not be enough to eat because of a lack of money? ?Yes ?No 
 
Are you? ?single  ?CL  ?married   ?divorced/separated ?widowed 
 
CURRENT RELATIONSHIP WITH BABY’S FATHER? ?Yes ?No    
 
HOW SATISFIED ARE YOU WITH THE RELATIONSHIP?       ? very     ? somewhat      
? not satisfied 
 
EDUCATION: What grade did you finish?   1 Grade 8 or less    1 Grade 9 – 11              1Grade 
12  1Some post-secondary  1Post-secondary 1Some University  1University 
 
ETHNIC BACKGROUND 
Are you?  1 Caucasian    1 Treaty –Status  1 Non-Status  1 Métis  1 Other 
 
 
 
Healthy Mother Healthy Baby  
CLIENT INTAKE INFORMATION 
Referral Date: HMHB# 
Assessment Date: Health Card #  
DOB: Day           Month              Year     AGE: EDC:  Day         Month                Year               
Appendix F 
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PRESENT PREGNANCY 
Date of first pregnancy check-up_______________ Who did you see? ?Doctor__________ 
 
What birth control did you use?   ?none   ?condom  ?BCP  ?Mirena/IUD   ?Depo  
other__________ 
 
Did you plan this pregnancy?    ? Yes    ? No    ? sort of 
 
Do you plan to keep the baby?   ? Yes    ? No    
 
How do you feel about the pregnancy?   ?happy  ?scared  ?overwhelmed  ? not happy 
 
How does your family feel about the pregnancy?  ?happy   ?unsure  ?overwhelmed  ?not happy 
 
How would you rate your overall health today?      ?Excellent    ?Very Good    ?Good    ?Fair    
?Poor 
 
Do you plan to breastfeed?    ?Yes   ?No   ?Undecided 
Are you interested in Prenatal Classes?     ?Yes   ?No   ?Undecided 
 
 
 
 
 
PAST BIRTHS/ PREGNANCIES:   G___P___T___P___A___L___  
 
NAME 
DOB 
 
M 
F 
Birth 
Wt 
Gest Complications/Comments Anomalies 
or problems 
with child 
       
       
       
       
       
HEALTH HISTORY-check which things you have experienced problems with 
? severe nausea/vomiting 1 HIV 1 thyroid 
? spotting/bleeding 1 Strep B 1 heart disease 
? headaches 1 anemia 1 allergies 
? UTI 1 Rh factor 1 surgeries 
1 vaginal  infection 1 diabetes  
1 STIs 1 seizures 1 other 
1 Hepatitis 
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CURRENT PREGNANCY-please check those that apply 
? severe nausea/vomiting 
? spotting/bleeding 
? cramps 
? headaches 
? multiple preg 
? placenta previa 
? incompetent cervix 
? premature labour 
? PIH/Swelling 
? UTI 
? vaginal infection  
? StrepB  
? anemia 
? Rh factor 
? Diabetes 
? dental problems 
? other 
  Medication Reason Amount Frequency 
    
    
    
 
MENTAL HEALTH/EMOTIONAL/PSYCHOLOGICAL HISTORY 
Do you have a history of depression? ?Yes ?No  When_____  Treated  ?Yes ?No Medication  
?Yes ?No    
Did you have depression in previous pregnancy?  ? Yes ? No   when____ Treated  ?Yes?No  
Medication          ?Yes ?No  
Have you had postpartum depression? ?Yes ?No   when____  Treated ?Yes ?No  Medication  
?Yes ?No  
Do your moods go up and down?    ?Yes ?No    
Did your mother or any of your sisters have depression before or after giving birth?   ?unknown 
Mother ? Yes  ? No     sister: 1 ? Yes ? No   2.? Yes ? No   3.? Yes ? No     
 
What things are causing you the most stress right now?    ?nothing right now      
?being pregnant     ? partner/relationship   ?not enough money    ?children      ?family  
?where I live      ? health of my baby       ?birth of my baby       ?health          ?work     ?school              
?  Other  ________________   _______________   
 
Do you have someone to turn to for emotional support?  ?Yes ?No     If yes, who gives you 
support?    
? Partner  ? Mother  ? Friend   ? Female relatives   ? Other______________ 
Who of these gives you the most support? ____________ 
Can you count on that person to care about you no matter what? Yes ?  No ?   
 
Has anyone ever hit, slap, restrained, punch, pinch, kick, beat you?      ? Yes       ? No       
Has anyone ever yell, belittle, berate, blame, neglect?       ? Yes       ? No       
Has anyone touched you against your will, raped you?     ? Yes      ? No     
 
Have you had counselling in the past?       ? Yes      ? No   
If yes, what for?   ? depression   ? relationship   ? addiction   ? eating disorder   ? abuse    
?other _______________________________________________________________ 
 
Are you seeing a counsellor right now?     ? Yes      ? No   
If yes, why?  ? depression   ? relationship  ? addiction   ? eating disorder   ? abuse   
 
Do you have any legal problems?  ? Yes      ? No   
 
Date:  ________________      Interviewer:_______________________________________ 
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 #_____            EARLY PREGNANCY     
 
How much do you exercise? (walking for 20 minutes, swimming etc.) 
   Every day             ? 
   2-3 times a week  ? 
   Occasionally         ? 
   Never                   ? 
How much do you smoke?  (√  one) 
More than a pack/day   ?  
5-20/day                ?   
Less than 5 a day          ?  
Quit since pregnant      ? 
Quit before pregnant    ? 
I never smoked              ? 
If you do/did smoke cigarettes, how old were you when you started smoking?_____ 
Does anyone else smoke inside your home?  Yes?  No? 
How often did you drink beer or other alcohol?  (√ all that apply) 
Occasional drink or 2      ?     
1-2 drinks a day              ?  
5+ drinks at one time      ?   
Quit since pregnant        ? 
Quit before pregnant     ?  
I never drank alcohol      ?  
If you do/did drink alcohol, how old were you when you started drinking?____________ 
How often did you use drugs such as marijuana, crystal meth. cocaine? (√  one) 
Regular (every day)         ?  
Occasionally                    ? 
Quit since pregnancy       ? 
Quit before pregnant      ?  
I never use such drugs    ?  
If you do/did use drugs, at what age did you start using drugs?____________ 
 
Your family income: (√  one only) 
Social/Band assistance    ? 
Less than $20,000./yr    ?  
$20,000 -39,000./yr     ?  
$40,000 -60,000./yr      ?  
More than $60,000./yr   ?Other __________________ 
 
Is there anything else you would like to say about how you feel right now? 
 
 
 
Thank you for your time today 
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Appendix G Westside Clinic    #____        Today’s Date__________ 
                                                          
Where do you live?  1own house  1rent house/apartment  1live with parents   1room & board   
1YWCA   1other   
# of adults in household_____     # of children under 18______ Adequate/suitable   Yes?  No?   
1unknown       Plan to move:  Yes?  No?   when? _______________ 
 
Do you have financial concerns:  Yes?  No?     
In the past 12 months, did you or anyone else in your house  
      Not have enough food to eat?  Yes?  No?   
      Worry that there would not be enough to eat because of a lack of money?  Yes?  No? 
 
Do you work outside your home? Yes?  No?   
Are you?    ?Single     ?Common Law      ?Married  ?Divorced   ?Separated    ?Widowed 
Are you in a relationship with baby’s father ?Yes ?No   
How satisfied are you with the relationship?  ?very     ?somewhat     ?not satisfied 
 
Are you?   ?Treaty Status  ?Non Treaty   ?Métis   ?Caucasian   ?Other: Band_____________      
What grade did you finish?   1 Grade 8 or less     1Grade 9-11     1Grade 12     1Some post-
secondary  1Post-secondary 1Some University    1University  
 
What birth control do you use?  ?none     ?condom     ?birth control pill    ?Mirena/IUD     
?DepoProvera      ?other 
Did you plan this pregnancy?       ?Yes   ?No         ? sort of  
Do you plan to keep the baby?    ?Yes   ?No  
 
How do you feel about the pregnancy?      ?happy   ?scared    ?overwhelmed    ?not happy 
How does your family feel about the pregnancy?  ?happy ?unsure  ?overwhelmed  ?not happy 
 
Do you plan to breastfeed?  ?Yes   ?No   ?Undecided 
Do you plan to go to prenatal classes?   ?Yes   ?No   ?Undecided 
 
Have you had depression before?                   ?Yes ?No     when______  treated ?Yes ?No     
Medication?Yes   ?No    
Were you depressed in other pregnancies?    ?Yes ?No     when?_____   treated ?Yes ?No     
Medication?Yes   ?No  
Have you had Postpartum depression?            ?Yes ?No     when______   treated ?Yes ?No     
Medication?Yes   ?No    
Do your moods go up and down?   ?Yes ?No      
 
Did your mother or any of your sisters have depression before or after giving birth? ?Yes ?No   
?Unknown     Mother?Yes  ?No   sister1.?Yes ?No   2.?Yes ?No   3.?Yes ?No         
 
Has anyone ever hit, slap, restrained, punch, pinch, kick, beat you? ?Yes ?No       
Has anyone ever yell, belittle, berate, blame, neglect? ?Yes ?No       
Has anyone ever touched you against your will, raped you?  ?Yes ?No     
 
Have you had counselling in the past? ?Yes ?No   
If yes, what for?  ?depression    ?relationship   ?addiction  ?eating disorder   ?abuse    ?other 
Are you seeing a counsellor right now? ?Yes ?No   
If yes, what for?  ?depression    ?relationship    ?addiction  ?eating disorder   ?abuse   ?other 
Do you have any legal problems?  ?Yes ?No 
How would you rate your overall health today?    Excellent?     Very Good?      Good?     Fair?      Poor? 
What things are causing you the most stress right now?    ?nothing right now      
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  ?being pregnant        ? partner/relationship   ?not enough money      ?children       ?family 
  ?where I live       ? health of my baby       ?birth of my baby       ?health          ?work              
  ?school   Other  ?________________   _______________  _________________ 
 
Do you have someone to turn to for emotional support? ?Yes ?No      if yes, who gives you support?   ?Partner     
?Mother     ?Friend____________ ?Female relatives    Other,  who? _________ 
Who of these gives you the most support? ___________  
Can you count on that person no matter what? Yes?  No?   
 
Are you in a relationship now? Yes?  No?   
If yes,  How satisfied are you with the relationship?  very?  somewhat?  not satisfied?                     
Are you seeing a counsellor right now?   Yes?  No?:    
If yes, for what?  Depression?  Stress?   Relationship?   Alcohol?   Other?  please specify _____  
 
How much do you exercise? (walking for 20 minutes, swimming etc.) 
   Every day             ? 
   2-3 times a week  ? 
   Occasionally         ? 
   Never                   ? 
How much do you smoke?  (√  one) 
More than a pack/day   ?  
5-20/day          ?   
Less than 5 a day          ?  
Quit since pregnant      ? 
Quit before pregnant    ? 
I never smoked              ? 
If you do/did smoke cigarettes, how old were you when you started smoking?_____ 
Does anyone else smoke inside your home?  Yes?  No? 
How often did you drink beer or other alcohol?  (√ all that apply) 
Occasional drink or 2      ?     
1-2 drinks a day              ?  
5+ drinks at one time      ?   
Quit since pregnant        ? 
Quit before pregnant     ?  
I never drank alcohol      ?  
If you do/did drink alcohol, how old were you when you started drinking?____________ 
How often did you use drugs such as marijuana, crystal meth. cocaine? (√  one) 
Regular (every day)         ?  
Occasionally                    ? 
Quit since pregnancy       ? 
Quit before pregnant      ?  
I never use such drugs    ?  
If you do/did use drugs, at what age did you start using drugs?____________ 
Your family income: (√  one only) 
Social/Band assistance    ? 
Less than $20,000./yr    ?  
$20,000 - 39,000./yr     ?  
$40,000 - 60,000./yr     ?  
More than $60,000./yr   ? 
Is there anything else you would like to say about how you feel right now?                                                   
 
 
Thank you for your time today 
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Appendix H Validation and Psychometric Properties of the EPDS 
Author Sample size Ante-
natal 
(weeks) 
Post-
natal 
(weeks)  
Cut-
off  
Psychometric properties, tools, 
analysis 
Interpretation, comments 
Adouard(227) 60 28-34 
weeks 
 11.5 Compared with HAD and 
diagnostic interview with 
psychiatrist 
Sensitivity-80%  Specificity-80% 
Validation of EPDS in obstetrically 
high-risk women in France 
Beattie(154) 117  Varied 11.5 Sensitivity-94%    Specificity-86% 
PPV-56%              NPV-99% 
Major depression; Urban Aboriginal 
women 
Bolton et 
al.(67) 
407  
 
Antenata
l clinic 
 12/13  States, good estimate of prevalence 
of depression- high risk women 
Cox et al. 
(50) 
84 
 
 6  12/13 Compared-RDC (SPI)1  
Sensitivity-86% 
Specificity-78%          PPV-73% 
Identified all women with PPD - 
original validation of EPDS 
Da-Silva et 
al.(6) 
218; 33- at 
home 
’3rd 
trimester
’ 
Not 
specified 
>13 Sensitivity-73%   Specificity-
90.5% 
Low income. Brazilian validation 
study 
Eberhard-
Gran et 
al(240) 
310; 56-
examined 
 6 >10 Compared2 DSM-IV  
PRIME-MD:  
Sensitivity-100% 
Specificity-87.2% 
Norwegian community sample-
Validation Study 
Harris et 
al.(241) 
147  6-8 12/13 Compared-DSM-III psychiatrist 
interview 
Sensitivity-95%    Specificity-93% 
EPDS performed better than  
BDI-Sensitivity-68%  Specificity-88%  
Murray, 
Carrothers(2
42) 
674  6 12 Compared-RDC (SPI)1 
Sensitivity 92.5%   Specificity-
88% 
PPV-56.8% 
Community Mail-out Sample 
Murray, 
Cox (152) 
100 28, 34   >14/1
5 
 
Compared-RDC (SPI)1 
Sensitivity-100% 
Specificity-96%   PPV-60% 
Major depression: 
misclassification 4%  
100% sensitivity for major depression 
AD at scores 11-15 --original 
validation of EPDS in pregnant 
women 
Recommend 12/13 cut off 
HAD-Hospital Anxiety and Depression Scale; RDC -Research Diagnostic Criteria for minor and major depression. SPI-Standardised 
Psychiatric Interview, community based semi-structured psychiatric interview. 2DSM-III Diagnostic and Statistical manual of mental 
disorders. PRIME-MD-Primary Care Evaluation of Mental Disorders; MADRAS-Montogomery-Asber Depression Rating Scale; SCL-25-
Hopkins Symptom Checklist. 
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Appendix I              Feelings in Pregnancy and Motherhood  #_____    
Please underline the answer, which comes closest to how you have felt in the past 7 days: 
I have felt happy:  
  Yes, most of the time 
Yes, some of the time 
No, not very often 
No, not at all 
In the past 7 days: 
1. I have been able to laugh and see the funny side of things: 
As much as I always could 
Not quite so much now 
Definitely not so much now 
Not at all 
2. I have looked forward with enjoyment to things: 
As much as I ever did 
Rather less than I used to 
Definitely less than I used to  
Hardly at all 
3. I have blamed myself unnecessarily when things went wrong: 
Yes, most of the time 
Yes, some of the time 
Not very often 
No, never 
4. I have been anxious or worried for no good reason: 
No, not at all 
Hardly ever 
Yes, sometimes 
Yes, very often 
5. I have felt scared or panicky for no very good reason: 
Yes, quite a lot 
Yes, sometimes 
No, not much 
No, not at all 
6. Things have been getting on top of me: 
Yes, most of the time I haven’t been able to cope at all 
Yes, sometimes I haven’t been coping as well as usual 
No, most of the time I have coped quite well 
No, I have been coping as well as ever 
7. I have been so unhappy that I have had difficulty sleeping: 
Yes, most of the time 
Yes, sometimes 
Not very often 
No, not at all 
8. I have felt sad or miserable: 
Yes, most of the time 
Yes, quite often 
Not very often 
No, not at all 
9. I have been so unhappy that I have been crying: 
Yes, most of the time 
Yes, quite often 
Only occasionally 
No, never 
10. The thought of harming myself has occurred to me: 
Yes, quite often 
Sometimes 
Hardly ever 
Never           
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Appendix J                                                                                            #________   
       Feelings in Pregnancy and Motherhood -SCORE SHEET     Gestation ______weeks   
1. I have been able to laugh and see the funny side of things: 
  As much as I always could    0 
  Not quite so much now    1 
  Definitely not so much now    2 
  Not at all      3 
 
2. I have looked forward with enjoyment to things: 
As much as I ever did    0 
Rather less than I used to                   1 
Definitely less than I used to     2 
Hardly at all     3 
 
3. I have blamed myself unnecessarily when things went wrong: 
Yes, most of the time    3 
Yes, some of the time    2 
Not very often     1 
No, never      0 
 
4. I have been anxious or worried for no good reason: 
No, not at all     0 
Hardly ever     1 
Yes, sometimes     2 
Yes, very often     3 
 
5. I have felt scared or panicky for no very good reason: 
Yes, quite a lot     3 
Yes, sometimes     2 
No, not much     1 
No, not at all     0 
 
6. Things have been getting on top of me: 
Yes, most of the time I haven’t been able to cope at all 3 
Yes, sometimes I haven’t been coping as well as usual 2 
No, most of the time I have coped quite well  1 
No, I have been coping as well as ever   0 
 
7. I have been so unhappy that I have had difficulty sleeping: 
Yes, most of the time    3 
Yes, sometimes     2 
Not very often     1 
No, not at all     0 
 
8. I have felt sad or miserable: 
Yes, most of the time    3 
Yes, quite often     2  
Not very often     1 
No, not at all     0 
 
9. I have been so unhappy that I have been crying: 
Yes, most of the time    3 
Yes, quite often     2 
Only occasionally     1 
No, never      0 
 
10. The thought of harming myself has occurred to me: 
Yes, quite often     3 
Sometimes     2 
Hardly ever     1 
Never      0   SCORE_______________ 
REFERRAL     ?Refused reason__________________________ 
?Family Physician        ?KidsFirst        ?Community Clinic       ?Crisis      ?Emergency     ?Mental Health Services             
?Counsellor ?Other ____________________________ Comments:    
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Appendix K Study of Feelings in Pregnancy and Motherhood: Consent  
 
Please read this consent carefully and feel free to ask any questions that you have 
 
Purpose of the Study: We hope this study will help us understand how women feel during and after 
pregnancy. You will be given 2 short questionnaires that will ask how you have been feeling and about 
your activities. The questions take about 10 minutes to complete. There are no right or wrong answers. 
The nurse will discuss the findings and any possible follow-up with you. The questionnaires will be given 
to you today, again when you are 26-32 weeks pregnant, and about 2 weeks after the baby is born. 
 
Potential Risks: If any questions upset you, the nurse will discuss these concerns with you. If your 
responses to the questions indicate concerns about how you are feeling, the nurse may suggest that 
you see your family doctor or other health care provider.  Some resources here in Saskatoon: 
Doctor _________________                                     Counsellor_____________           
Postpartum Support Program-hotline    655-4665    Mobile Crisis Service                  933-6200  
Mental Health Services                         655-7950    Saskatoon Community Clinic        652-0300 
Healthy Mother Healthy Baby               655-4633      Emergency: Royal University Hospital 655-1000 
St. Paul’s 655-5000, City Hospital 655-8000 
 
Confidentiality: Confidentiality is assured; researchers will only have a number to identify you. The 
findings of the study will exist only as grouped completely anonymous data and kept on your chart. The 
findings will be shared with the program and may be used in a student thesis, presented at 
conferences, and published in journals. As required by the University of Saskatchewan, the completed 
questionnaires will be kept in a locked cupboard at the Healthy Mother Healthy Baby or Saskatoon 
Community Clinic until the study is over and then held for 5 years in a locked unit at the University of 
Saskatchewan by Dr. N. Muhajarine. 
 
Right to Withdraw: You may withdraw from the study or refuse to answer individual questions for 
any reason, at any time, without any sort of penalty. Participation is voluntary and refusal to 
participate in the study will not result in any change in service or care provided. If you withdraw from 
the study, any data about you will be destroyed.  
 
Questions:  If you have any questions about the study, please ask the nurse or contact the 
researchers below at any point: Angela Bowen   or   Dr. Nazeem Muhajarine, 
       Department of Community Health and Epidemiology, 
University of Saskatchewan. 966-7930 
 
The University of Saskatchewan Behavioural Sciences Research Ethics Board approved this study on 
September 10, 2004. If you have any questions about your rights as a participant please call the 
Office of Research Studies at 966-2084.   
 
Consent to Participate:  
I have read and understood the above; I have had an opportunity to ask questions and my questions 
have been answered to my satisfaction.   
I consent to participate in the study described above; I understand that I may withdraw this consent 
at any time without any effect on my care. A copy of this consent form has been given to me.  
 
_____________________                  _______________________                   _________ 
Signature of Participant                            Caregiver               Date 
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Appendix L 
Request for Waiver of Parental Consent 
 
Some of clients who will be included in the study are under 18 years of age. All pregnant 
teenagers in Saskatoon are offered an opportunity to be followed by Healthy Mother 
Healthy Baby (HMHB), any girls who are under age 18 will only be invited to join the 
study if they are or will be participating in the HMHB program. Girls under 18 who 
attend the Community Clinic will be referred to HMHB. These teenagers are considered 
by the Saskatoon Health Region to be emancipated minors and as a result, do not require 
parental consent for participation in the HMHB program or to receive any of the program 
benefits (vitamins, supplements), education, or assessments or for other procedures 
related to the pregnancy.  
 
1. The waiver is necessary for a number of reasons: 
a. The HMHB program does not require parental consent 
b. Many of these participants are not living with their parents 
c. To ensure that the study questionnaire is completed at the appropriate time 
 
2. Potential risks to the clients include some upset, while this is a potential risk, it did 
not occur during the pilot study.  
a. All of the clients under 18 are under the care of one of two Maternal-Child 
Nurses throughout their contact with the HMHB program, therefore this 
Registered Nurse will be available during administration of all aspects of 
administration of the questionnaire (the three times that the tool is 
administered: upon admission to the program, at 28-32 weeks, and 2 
weeks postpartum). 
b. Clients are provided a list of potential contacts for help (in the consent 
form) and will be referred to their family physician and mental health 
services should the questionnaire indicate a need for help. 
 
3. As emancipated minors, there is no consent required by the parents for any other 
aspect of care provided by HMHB. It may then be considered inappropriate by 
these participants for the study to give their parents the option to withdraw their 
daughter from the study. 
 
The Maternal-Child Nurses who provide care to these participants work in conjunction 
with their teachers, social workers, and other caregivers and parents where appropriate. 
The Nurse will assess if the girl is mature enough (cognitively and emotionally) to 
complete the questionnaire. 
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Appendix M  
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Appendix N       
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Appendix Q WC Supplemental information         #_______________ 
Date of Birth ______ _________ __________    Age___ Postal Code ______ _______ 
Gestation when study done/first visit __________weeks 
 
 
 
 
 
 
 
 
  
 
CURRENT PREGNANCY-please check those that apply 
? Severe nausea/vomiting 
? Spotting/bleeding 
? Cramps 
? Headaches 
? Multiple pregnancy 
? Placenta previa 
 
? Incompetent cervix 
? Premature labour 
? Hypertension (high blood   
pressure)/swelling 
? Urinary Tract Infection 
? Vaginal infection  
? Strep B infection 
? Anemia 
? Rh factor 
? Diabetes 
? Dental problems 
? Other 
  
Medication/Vitamin 
Reason Amount Frequency 
       
       
       
       
PAST BIRTHS/ PREGNANCIES:  G______ P _____ T______ P______ A ______L______ 
NAME DOB 
 
M 
F 
Birth 
Wt 
Gest Complications/Comments Anomalies or 
problems with 
child 
 
 
Breastfed Lives 
with 
 
 
          
G=all pregnancies;  P>20 weeks gestation;  T=Term;  P=Preterm, <37weeks gestation; 
A=miscarriage<20wks/abortions; L=living 
HEALTH HISTORY-check which things the woman experienced problems with 
? Severe nausea/vomiting       1 HIV 1 Thyroid 
? Spotting/bleeding       1 Strep B Infection 1 Heart disease 
? Headaches       1 Anemia 1 Allergies 
? Urinary Tract Infection       1 Rh factor 1 Surgeries 
1 Vaginal infection       1 Diabetes 1 Hepatitis  
1 Sexually Transmitted Infections                 1 Seizures 1 Other 
1 Other 
